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Abstract  
With the constant development of new antibiotics, selective pressure is a force to reckon 
when investigating antibiotic resistance. Although advantageous for medical treatments, 
it leads to increasing resistance. It is essential to use more potent and toxic antibiotics. 
Enzymes capable of hydrolyzing antibiotics are among the most common ways of 
resistance and TEM variants have been detected in several resistant isolates. Due to the 
rapid evolution of these variants, complex phenotypes have emerged and the need to 
understand their biological activity becomes crucial. 
To investigate the biochemical properties of TEM-180 and TEM-201 several 
computational methodologies have been used, allowing the comprehension of their 
structure and catalytic activity, which translates into their biological phenotype. 
In this work we intent to characterize the interface between these proteins and the 
several antibiotics used as ligands. We performed explicit solvent molecular dynamics 
(MD) simulations of these complexes and studied a variety of structural and energetic 
features. 
The interfacial residues show a distinct behavior when in complex with different 
antibiotics. Nevertheless, it was possible to identify some common Hot Spots among 
several complexes – Lys73, Tyr105 and Glu166. The structural changes that occur during 
the Molecular Dynamic (MD) simulation lead to the conclusion that these variants have 
an inherent capacity of adapting to the various antibiotics. This capability might be the 
reason why they can hydrolyze antibiotics that have not been described until now to be 
degraded by TEM variants. The results obtained with computational and experimental 
methodologies for the complex with Imipenem have shown that in order to this type of 
enzymes be able to acylate the antibiotics, they need to be capable to protect the ligand 
from water molecules. 
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1. State of the Art 
1.1. Beta-lactamases – evolution and relevance 
Infectious diseases are nowadays accepted as one of the most important and relevant 
clinical conditions, and, many times, fatal. With the inclusion of antibiotics in the clinical 
practice, mankind has taken this problem as a ceased problem in the history of human 
diseases. However, the infectious agents have the capacity to resist the antibiotics action. 
Nowadays, the majority of the hospitals isolates are microorganisms highly resistant to 
antibiotics.1, 2 The ability to resist antibiotics can be associated with multiple factors but 
the most common is genetic mutation that leads to the production of a mutated protein. 
These proteins can be enzymes that increase the catalytic activity towards antibiotics or 
increase the resistance to the inhibitors binding. Additionally membrane transporters that 
export antibiotics prior to their binding to the target may be also mutated. The 
microorganisms that do not possess any mutation in their genome conferring resistance 
to the antibiotics may obtain these kinds of genes through the acquisition of mobile 
genetic elements such as plasmids and transposons.1, 3, 4 These mechanisms can be 
considered as primary mechanisms of resistance (resistance occur at the primary level of 
metabolism). Nevertheless, mechanisms of resistance affecting secondary metabolism 
have also been described (biosynthesis of modified β-lactams that are antagonist of the 
modified proteins).5  
Specific primary mechanisms of resistance can be associated with Gram-positive and 
Gram-negative bacteria. In Gram-positive bacteria, acquisition of resistance is obtained 
through the production of β-lactamases (inactivation of the antibiotic) and production of 
mutated Penicillin Binding Proteins (PBPs).5, 6 Several mechanisms of resistance can be 
obtained with the mutation of these targets. It is possible that a less sensitive PBP is 
produced either by mutation of an endogenous protein or with acquisition of a new PBP. 
It is possible to up regulate the production of PBPs allowing the pathogen to produce 
peptidoglycan.7 The most common mechanism in Gram-negative bacteria is the 
production of β-lactamases but these organisms can also present mutation of outer 
membrane proteins such as porins. This allows them to avoid one of the mechanisms for 
the crossing of the antibiotic through the outer membrane to reach the active site (PBPs) 
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and the production of efflux pumps capable of remove the antibiotics from the 
periplasma and transporting them out of the bacteria.5, 6  
Nowadays, it is accepted that the increase of antibiotic resistance is due to the negligent 
use of antibiotics or the lack of these to perform a proper medical treatment – World 
Health Organization (WHO). However, the emergent resistance of β-lactams was detected 
even before penicillin was ever used in medical practice.1, 2 The first β-lactamase was 
described, in 1940, by Chain, E. et al in E. coli, as a penicillinase but soon this resistance 
had appeared in others species, particularly in staphylococci.1, 8 It is believed that β-
lactamases have PBPs as their ancestors and that by the acquisition of new mutations, 
evolved and gain the capability to acylate and deacylate β-lactams.9 So, it becomes clear 
why PBPs and β-lactamases are both serine proteases with similar active sites (in both 
exists a lysine near the catalytic serine). However, in PBPs the lysine is the initial base but 
in β-lactamases its role is not yet fully understood. Another major dissimilarity between 
the active site of these two types of proteins is the presence of a new glutamate residue 
in the Ω-loop in the β-lactamases.10  
The most common isolated β-lactamases are TEMs and SHVs, as well as extended 
spectrum β-lactamase (ESBL). Other examples are OXAs and SHO.1, 11, 12 After the 
discovery of TEM-1(1963), its prevalence increased and, in 20 years, various variants of 
TEM-1 were detected with altered kinetic properties such as the ability to hydrolyze 
extended spectrum β-lactam antibiotics and to resist inhibition (inhibitor resistant - IRT).2 
 
1.2. TEM-1 characterization 
The antibiotics action with TEM-1 occurs by hydrolysis of the amide group of the β-
lactamic ring by a serine residue in the active binding site, which allows the classification 
of this enzyme as class A β-lactamase (classification according to Ambler, 1980).13 Despite 
this classification still being used, it does not allow to clearly and efficiently differentiate 
some β-lactamases with distinct properties. To overcome this situation a more complex 
system of classification was developed by Bush.14 This system uses several of the enzyme 
characteristics such as molecular structure, biochemical properties and genetic 
sequence.14 
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1.2.1. TEM-1 structure 
 β-lactamase TEM-1 (Figure 1) is organized in three domains that are organized Sandwich-
like ((α-Helices /β-sheets/ α-Helices). Its binding site is located between the β-sheets 
domain and the domain that includes the α2-Helix.13, 15 
 
Figure 1: Structural representation of TEM-1 (PDBID:1ZG416) with some of the key secondary structures identified. 
The protein backbone is highly ordained and stable and a higher variability is observed in 
the loops due to the lack of a well defined secondary structure.17  The high variability of 
the position of loop Ω, may influence the proximity of water molecules near the active 
center, more precisely near the Glu166 residue. Figure 2 illustrates the proximity of the 
residues that do not catalyze the reaction (highlighted in orange) to the catalytic residues, 
reason why they may influence the ability of this enzyme to hydrolyze substrates (leading 
to a different orientation of the catalytic residues, enlargement of the catalytic pocket or 
displacement of water molecules in the catalytic pocket). However, there is a tradeoff: 
the destabilization of the enzymatic structure. The Ser130 residue has an important role 
in the catalysis, mainly due to its proximity to the residue Ser70. It is very important in the 
reaction with inhibitors of β-lactamases as it is the residue that is irreversibly inhibited.1, 
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13, 17-21 Kollman et al. 22 have shown that Ser130 can be responsible for the β-lactamic ring 
opening due to the donation of an hydrogen, after the nucleophilic attack by Ser70. 
 
Figure 2: Structural representation of TEM-1 (PDBID:1ZG416) with the catalytic residues in a white  stick 
representation and the residues near the catalytic pocket (the ones that can affect the enzymatic catalyzes) 
highlighted in orange. 
 
1.2.2. TEM-1’s activity 
The process responsible for the  resistance to antibiotics can be explained by two main 
processes: acylation and deacylation.13 In the acylation process, the Ser70 residue is 
deprotonated in order to perform the nucleophilic attack to the carbon in the carbonyl 
group in the β-lactamic ring. The deprotonation process is achieved through the 
interaction of a water molecule with Glu166, being the latter the primary base of the 
reaction.18, 23 After accessing the importance of the Lys73 in the process, other theories 
refer the possibility of this residue act as a base in the enzymatic process. However, it can 
also be important to stabilize the ligand in the hydrolysis reaction. Thus, the mechanism is 
yet not fully understood and many theories have been described.13, 18, 22, 23 The 
deacylation process of the formed intermediary occurs with an activated water molecule 
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bound by hydrogen bridges to Glu166, releasing Ser70 from the β-lactamic ring in its 
protonated form.13 
 
1.2.3. Extended spectrum β-lactamases - ESBL 
For decades new antibiotics were developed with clinical usability. The usage of new 
antibiotics induced a selective pressure over microorganisms, which led to a co-
development of the latter with production of enzymes capable of antibiotic degradation.3, 
12 
TEM-1 degrades efficiently some penicillins but, despite its poorly filled out active center, 
it does not possess the needed space to accommodate big lateral chains like the ones in 
ceftazidine and cephotaxime (3th generation cephalosporins).2, 12, 24 With the introduction 
of this type of compounds, these enzymes have evolved. Up to 2001 1 mutations were 
observed only on a small number of residues. After Bradford et al. compile the mutations 
on the existent ESBLs, not only several new enzymes have been identified but mutations 
on several different residues can now be observed.  TEM ESBL started to be identified and 
isolated since the 70s, being nowadays more than 100.1, 25 
The unusual mutations observed in this phenotype increase the plasticity of the active 
center, which allowed its enlargement, despite the fact that they do not occur in the 
active center. This enlargement means that the enzymes with this phenotype can acylate 
larger β-lactam antibiotics, inactivating them. ESBL have shown to degrade extended 
spectrum β-lactams (around 100 times more efficient) but with decreased catalytic 
activity for penicillins (100 fold less efficient).26 The enlargement and increase of plasticity 
of the active center do occur but with a decreased enzymatic stability.27 Having this in 
consideration, it is understandable that enzymes that present an additional factor that 
leads to higher enzymatic stability are naturally selected. This is mainly accomplished by 
evolutionary pressure, by the use of antibiotics with bigger lateral chains.2, 24 In several 
ESBL, one factor was identified: the Met182Thr mutation. This mutation does not lead to 
any effect on the catalytic activity of the enzyme. Therefore, by itself does not bring any 
evolutionary advantage, which might be the reason why any enzyme was identified with 
just this mutation.2, 3, 19, 28 Wang X. et al. proved that bacteria that produce enzymes with 
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the referred mutation are less susceptible to 3th generation cephalosporins, when 
compared with the wild type. Effect that is observed in a higher degree with the increase 
of the temperature.12 These observations may be explained by the increase of the proteic 
stability but it is still possible that it promotes the correct folding of the TEM variants.24 
A small amount of amino acids mutations with a high importance for the yield of 
extended spectrum enzymes have been described. The most common ones are: 
Leu21Phe, Gln39Lys, Glu104Lys, Arg164His or Arg164Ser, Gly238Ser and Glu240Lys.1, 2, 25, 
29 Figure 3 is a diagram of the various mutations, relative to TEM-1 sequence, of the ESBLs 
β-lactamases with sequence available in reference 25 at the time of this review. 
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Figure 3: Diagram of the mutations of TEM ESBL enzymes, compared to the TEM-1 sequence. Scheme based on available sequences and phenotype in Jacoby database25. 
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1.2.4. Inhibitors resistant beta lactamases - IRT 
The β-lactamases with the ability to resist the inhibition by clavulanic acid were 
discovered in the early 90s.26 They were identified mainly from samples of E. coli but also 
from samples of other lineages, like K. mirabilis and C. freudii.1 
These types of enzymes confer resistance to clavulunate/clavulanic acid and sulbactam. 
Hence, microorganisms that produces them are resistant to Clavamox treatment 
(amoxicillin-clavulanic acid), ampicillin-sulbactam and other inhibitor combinations.2, 11, 29-
31  IRTs remain susceptible to Tazobactam, and this treatment may be performed in 
combination with piperacillin.31 Mutations in the residues Met69, Ser130, Trp165, 
Arg244, Arg275 and Arg276 appear to be relevant in promoting this phenotype and its 
identification is more common in clinical isolates.1, 2, 21, 26, 32 Substitutions in the Met69, 
Ser130, Arg244 and Arg276 residues were identified as resistance promoters ampicillin-
clavulanic acid combinations and other studies have shown that mutations in Met69, 
Trp165 and Arg276 promote resistance to cephtazidine-clavulanic acid treatment.1, 20, 32, 33 
Mutations on the Arg275 residue do not promote considerable resistance to clavulanic 
acid inhibition. Nevertheless, mutations for Leu and Gln have been identified to increase 
cefotaxime resistance, suggesting that Arg275 mutations may promote resistance to 
inhibitors and β-lactam antibiotics.2, 24 Figure 4 is a diagram of the mutations, relative to 
TEM-1, of the IRTs β-lactamases with sequence available in reference 25 at the time of this 
review. 
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Figure 4: Diagram of the mutations of the TEM IRT enzymes, compared to the TEM-1 sequence. Scheme based on 
available sequences and phenotype in Jacoby database.25 
 
The inherent mechanism of the inhibition is identical for all inhibitors and, unlikely the 
mechanism of β-lactam hydrolysis, is already well known.26  It comprehends 8-10 
different intermediaries in the inactivation pathway and derives of conventional 
hydrolysis intermediaries.20 The inhibitors form a covalent bond between residues Ser70 
and Ser130 leading to the irreversible inactivation of the enzyme due to deprotonation of 
the Ser130 residue.21, 26 Despite the hydrolytic pathway being 100 times faster than the 
inactivation pathway, the latter is irreversible, which leads to the inhibition of all the 
enzymes in the microorganism and loss of its activity.21 Clearly, Ser130 is essential to the 
inactivation via and its role is very important to the IRT phenotype. 
Other described mutations do not present direct interaction with the inhibitor nor with 
the proteic neighborhood of the active center. However, it is possible that these 
mutations cause torsion of Ser130 side chain, deflecting it from the active center, which 
leads to resistance to inhibitors.2, 26 IRT TEMs are less capable of hydrolyzing β-lactam 
antibiotics. As they are resistant to the inhibitors, have the ability to overcome this aspect 
and therefore, be resistant to the various treatments.21 Mutants that present mutations 
in residues that are typically responsible for the EBSL and IRT phenotype, normally 
present just one of the phenotypes. However, it have been identified some mutants (i.e. 
TEM-50 or CMT-1) that confer resistance to clavulanic acid and present the ability to 
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hydrolyze large spectrum cephalosporins. 11, 25 Several others have also been described as 
CMT or CMT-type enzymes. Although CMT variants present resistance to β-lactamase 
inhibitors, some can still be inhibited by the clavulanic acid at a higher rate than IRT 
variants. These are fundamental evidences that β-lactamases with more complex 
phenotypes and higher potential to promote resistance to treatments are evolving.34 
Figure 5 is a diagram of the mutations described until now regarding the CMT/CMT-type 
phenotypes in comparison with the TEM-1 gene.25 
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Figure 5: Diagram of the mutations of the TEM CMT/CMT-type enzymes, compared to the TEM-1 sequence. Scheme based on available sequences and phenotype in Jacoby database25.
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1.2.5. Previously described TEM variants 
For several years, researchers have study this family of enzymes. Such searching for 
knowledge concerning TEM enzymes, include the comprehension of their enzymatic 
mechanisms and shad light into the way they are evolving for better predicting their 
biological effect (antibiotic resistance). In the medical context, the comprehension of the 
genetics and biochemistry of the various β-lactamases will allow the development of 
better therapeutic approaches towards the infection control caused by pathogens that 
produce TEM enzymes.  
Table 6 lists some of the most important and well described variants. It becomes clear the 
relevance of some residues for their structure and activity.      
Table 1: Biological and structural effect of the mutation of key residues of several TEM enzymes. 
Variant Mutation Biological effect Structural characteristics PDB ID 
Wild 
Type 
(WT) 
- 
Responsible for β-lactam 
antibiotics resistance 
(cephalosporins are moderate 
resistant). They open the β-lactam 
ring deactivating the molecule. 
- 1ZG413 
- S70G 
Less active than WT deactivating  
β-lactam antibiotics. It can still be 
active as Ser130 might perform the 
nucleophilic attack to the β-lactam 
ring or due the presence of an 
additional water molecule close to 
Gly70. 
Lack of nucleofilic properties at 
residue 70 side-chain. The overall 
structure is very similar to WT 
except conformation of Ser130 and 
backbone near this residue. 
1ZG613, 
21
 
TEM-76 S130G 
Less active than WT deactivating  
β-lactam antibiotics. Less prone to 
inhibition by clavulanate and 
tazobactam (K1>K1WT for pre-
acylation complexes) More stable 
at Tm than WT. 
Distance between Ser70 and Gly130 
is greater than in WT (7,3Å and 
6,7Å in WT). Rotation of Lys234 (N 
shifts 1,5Å). H-Bond between 
Lys73 and Ser70 does not exist (N 
of Lys73 moves 0,5Å). New water 
molecule near Ser130 is responsible 
for its activity. 
1YT421 
Frequent 
in many 
TEM 
mutants 
M182T 
Similar activity than WT. 
Increased stability (stabilizes 
ESBL). Differences between TEM 
with Met182Thr increases with the 
increase of the temperature. 
Met182 is 14,5Å from the active site 
and therefore, it does not affect β-
Lactamase activity. 
1JWP/ 
1M4012, 
18
 
TEM-69 
E104K 
R164S 
M182T 
ESBL 
Loss of H-Bond between Arg164 
and Asp179 and between Arg164 
and Glu171. Loss of secondary 
structure near residue 170 (α-Helix) 
increases the catalytic pocket. 
1JWP12 
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TEM-32 M69I M182T 
More stable than TEM-40 
(Met69Ile) and less stable than 
Met182Thr mutants. Resistance 
against β-lactamase inhibitors - 
IRT (Ser130 moves). Catalytic 
activity is reduced. 
RMSD Cα= 0,41Å Ser70 distortion 
causes a 64⁰ ᵡ1 of Ser130 (no longer 
makes H-Bonds with Ser70 and 
Lys73) Ser130 Oγ - Ser70 Oγ = 
5,5Å (3,2Å in WT) Ser130 Oγ - 
Lys73 Nζ = 5,4Å (3,8Å in WT). 
New water molecule near Ser130 
1LI026 
TEM-34 M69V 
More stable than WT. Resistant to 
inhibition (new H-Bond Ser130-
Lys234: reduced ability to perform 
a nucleofilic attack) 
RMSD Cα= 0,30Å Ser70 distortion 
causes a 27⁰ ᵡ1 of Ser130. H-Bonds 
between Ser130 with Ser70, Lys73 
and Lys234 (Ser130 Oγ - Lys234 Nζ 
= 2,8Å ; Ser130 Oγ - Lys73 Nζ = 
3,2Å). Two lone pairs are used to 
bond with the two Lys when in WT 
only one of these was verified. The 
rate of cross-linking between the 
two Ser is reduced, which leads to a 
lower inactivation. 
1LI926 
TEM-64 N276D 
IRT phenotype Kinact 35% inferior 
than in WT with clavulanic acid. 
Small or nonexistent inhibition 
with Tazobactam and Sulbactam. 
Overall structure similar to WT. 
Residues 272-290 (β-Sheet 
surface/α-Helix H11), 26-40 (N-
Terminal α-Helix H1) and 219-224 
(α-Helix H10) move. RMSD=0,52Å 
RMSD(Asp276)=0,75Å. New 
interaction  with Arg244 (Asp276 
Oδ2 - Arg244 Nη2=3,3Å). 
Nonexistent water molecule in the 
active site (less prone to inhibition). 
1CK332 
TEM-30 R244S IRT phenotype due to water displacement. 
Water displacement leads to lower 
affinity to inhibitor (Schiff’s Base 
from inhibitor goes away from 
Ser130). 
1LHY26 
Legend 1: RMSD: Random Medium Standard Deviation; WT: Wild Type 
 
 
1.2.6. Relevant aminoacids  
Table 1 stresses out the importance of some residues for the structure and activity of the 
various TEM variants. Their importance is related to their position in the protein as well as 
to specific pair interactions with residues in their microenvironment. Here we will 
characterize them: 
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(i) Met69 
The side chain of Met69 lies behind β3 forming a wall of the oxyanion pocket. By means 
of steric interactions it influences the position of Ala237 and Gly238. Due to the proximity 
with Ser70, it has an important role influencing the structural position of this residue and 
also of Ser130. (Figure 6-A)1, 26, 35 
(ii) Glu104 
This glutamic acid residue is located in a conserved loop, highlighted in yellow (101-111) 
and its hydrophilic side chain is exposed at the entrance of the binding site. Due to its 
direct contact with Asn132 (part of the conserved SDN loop, highlighted in green (130-
132), if mutated it might affect the entry of bulky ligands. (Figure 6-B)1, 29 
(iii) Ser130 
Serine 130 is part of a complex hydrogen bounding network that contributes for the 
stability of the active site and the deprotonation process of Ser70. This residue is highly 
conserved. However, even tough with consequences in the enzyme activity mutations or 
displacement of the side chain are tolerated. (Figure 6-C)1, 20, 21, 31 
(iv) Arg164 
This arginine residue is underneath the binding site in the Ω-loop (162-179). The side 
chain is linked with Glu171 and Asp179 by salt bridge interactions and hydrogen bonds. 
An alteration in this residue might lead to an altered stability and conformation of the 
loop, and therefore, changes in the active site and the position of the catalytic residues. 
(Figure 6-D)1, 29, 36 
(v) Met182 
Methionine 182 is distant from the active site but it has contact with the secondary 
structure in which Met69 is located. Mutations in this residue have been detected on 
clinical isolates but its role is not fully understood. (Figure 6-E)1, 26, 28, 29 
(vi) Ala237 
The side chain of alanine 237 is on the exposed side of β3, which faces the catalytic 
pocket. Therefore, the position of this residue influences the stability of β-lactam 
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antibiotics binding by hydrogen bonding with them (groups NH and CO of the backbone). 
(Figure 6-F)1, 19, 29, 37 
(vii) Gly238 
The side chain of glycine 238 is on the internal and more protected side of β3, close to the 
residue Met69. It has been demonstrated the importance of this residue both for the 
position of the β3, as well as the position of the Ω-loop (steric conflict model). This affects 
the active site volume. (Figure 6-G)19, 25, 29, 38(1, 12, 17, 22) 
(viii) Glu240 
This residue is located at the end of β3 and its side chain can interact with the 
substituents of bulky β-lactam antibiotics (i.e. cephalosporins). Mutations in this residue 
alone would not modify significantly the catalytic properties of the enzyme but it might 
compensate the destabilization of other mutations (i.e. Arg164Ser or Gly238Ser). (Figure 
6-H)1, 2, 39-41 
(ix) Arg244 
Arg244 is located in the β4 and its long side chain reaches over to the adjacent β-strand 
(β3) to the edge of the binding site. It is kept in place by two hydrogen bonds with 
Asn276. Arg244 together with Val216 can be responsible for holding a water molecule in 
place, which is thought to be important for the enzyme inactivation process. (Figure 6-I)1, 
29, 36, 42   
(x) Asn276 
This residue is located on the C-terminal α-helix (H11) and its carbonyl group interacts 
with Arg244 by two hydrogen bonds (Asn276 carbonyl group with guanidinium group of 
Arg244). A mutation in residue 276 will not affect the position of the surrounding residues 
(i.e. Arg244). However, the rotamer of the mutant will be substantially different for TEM-
1. As consequence, α1 and α10 will be displaced. (Figure 6-J)1, 29, 30, 32, 36 
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Figure 6: Structural representation of key residues of TEM-1 (PDBID: 1ZG416). In orange are highlighted the interacting 
residues. A: Met69; B: Ser104; C: Ser130; D: Arg164; E: met182; F: Ala237; G: Gly238; H: Glu240; I: Arg244 and 
Asn276. 
 
1.3. β-lactam structure and classification  
The first β-lactam antibiotic to be used in clinical practice was penicillin. It was discovered 
and rapidly described by Alexander Fleming in 1928 but was only used with success in 
medical practice in 1941, after the work of Howard Walter Florey and Ernst Chain.43 
β-lactams target the PBPs with success because this type of antibiotics mimics the D-ala-
D-ala dipeptide in the peptidoglycan and form a very stable acyl-enzyme complex 
inhibiting PBPs from synthesizing peptidoglycan.44 In fact, the deacylation step of these 
antibiotics can be up to six times slower when compared with β-lactamases.45 
β-lactam antibiotics always feature a very reactive cyclic amid – β-lactam ring - which is a 
part of the bicyclic structure that forms the “core” of the antibiotic. A few common ring 
rearrangements can be appointed: penam, penem, carbapenem, cefem and 
monobactam. 
Other class of antibiotics within the β-lactams is the β-lactamase inhibitors, which have a 
different structure and role in treatment. By themselves inhibitors do not treat infections 
but they are used to surpass the capability of infectious agents to degrade antibiotics 
used in the medical treatment.  
 
1.3.1. Penams 
After Fleming’s discovery of penicillin, several antibiotics with different activity spectrums 
have been developed for medical use. Methicillin is not used anymore in medical practice 
due to the use of more active penicilliase-resistant penicillins. Nevertheless, it is still in 
use in laboratory to determine the susceptibility of Staphylococcus aureus to the 
penicillinase-resistant penicillins. This class of β-lactam antibiotics has as bicyclic structure 
the β-lactam ring and a thiazolidinic ring. Both natural and synthetic antibiotics exist 
within this class.46 
 
  
42 
Table 2: Spectrum, pharmacodynamics and chemical structures of several penicillins.  
Class Name Type Mechanism of action 2D Structure 
P
en
ic
ill
in
s 
Pe
n
ic
ill
in
 
V
 
β-lactamase 
sensitive 
By binding to specific PBPs 
located inside the bacterial cell 
wall, Penicillin V inhibits the 
third and last stage of bacterial 
cell wall synthesis. Cell lysis is 
then mediated by bacterial cell 
wall autolysins. 
 
M
et
hi
ci
lli
n
 
Penicilli-
nase-
resistant 
penicillin 
Methicillin acts by inhibiting 
the synthesis of bacterial cell 
walls. It inhibits the 
transpeptidase enzyme 
(PBP2a) used by bacteria to 
cross-link the peptide (D-
alanyl-alanine) used in 
peptidoglycan synthesis. 
 
C
lo
x
a
ci
lli
n
 
Penicilli-
nase-
resistant 
penicillin 
By binding to specific PBPs 
located inside the bacterial cell 
wall, cloxacillin inhibits the 
third and last stage of bacterial 
cell wall synthesis. Cell lysis is 
then mediated by bacterial cell 
wall autolytic enzymes such as 
autolysins. 
 
A
m
o
x
ic
ill
in
 
Moderate-
spectrum 
penicillin 
Amoxicillin binds to PBP-1A 
located inside the bacterial cell 
well. Penicillins acylate the 
penicillin-sensitive 
transpeptidase C-terminal 
domain by opening the lactam 
ring. The inactivation of the 
enzyme prevents the formation 
of a cross-link of two linear 
peptidoglycan strands, 
inhibiting the third and last 
stage of bacterial cell wall 
synthesis. 
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A
m
pi
ci
lli
n
 
Moderate-
spectrum 
penicillin 
By binding to specific PBPs 
located inside the bacterial cell 
wall, Ampicillin inhibits the 
third and last stage of bacterial 
cell wall synthesis. Cell lysis is 
then mediated by bacterial cell 
wall autolytic enzymes such as 
autolysins. 
 
C
a
rb
en
ic
ill
in
 
Extended-
spectrum 
penicillin 
Carbenicillin exerts its 
antibacterial activity by 
interference with final cell wall 
synthesis of susceptible 
bacteria via PBPs inhibiting 
the third and last stage of 
bacterial cell wall synthesis. 
 
Legend 2: PBP: Penicillin Binding Proteins 
 
1.3.2. Cefems 
Cefems can be classified into five different classes depending on the bicyclic structure and 
substituents: cephalosporins, cephamycins, oxa-1-cephems, carba-1-cephems and others. 
More typically, they are divided according to their microbiological classification: division 
in classes, 1st-5th generation according to their microbial spectrum. According to this 
classification scheme cefoxitin (cephamycin) is often included with the 2nd generation 
cephalosporins, which present broad-spectrum activity. These antibiotics demand more 
refinement than penicillins to be effective. 
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Table 3: Spectrum, pharmacodynamics and chemical structures of several cephalosporins. 
 Class Name Type Mechanism of action 2D Structure 
C
ep
ha
lo
sp
o
ri
n
s 
C
ef
a
zo
lin
 1st gen, 
broad-
spectrum 
Cephalosp
orin 
Bacterial cell wall synthesis 
inhibition via PBPs affinity. It 
inhibits the third and last stage 
of cell wall synthesis. 
Effective against some species 
of Gram-positive bacteria.  
C
ef
u
ro
x
im
e 2nd gen, 
broad-
spectrum 
Cephalosp
orin 
Bacterial cell wall synthesis 
inhibition via PBPs affinity. It 
inhibits the third and last stage 
of cell wall synthesis.  
Effective against Gram-
positive and Gram-negative 
bacteria. It can cross the 
blood–brain-barrier  
C
ef
o
ta
x
im
e 3rd gen, 
extended-
spectrum 
Cephalosp
orin 
The bactericidal activity of 
cefotaxime results from the 
inhibition of cell wall 
synthesis via PBPs. 
Cefotaxime shows high 
affinity for penicillin-binding 
proteins in the cell wall 
including PBP Ib and PBP III.  
C
ef
ta
zi
di
m
e 3rd gen, 
extended-
spectrum 
Cephalosp
orin 
Bacterial cell wall synthesis 
inhibition via PBPs affinity. 
Effective against Gram-
positive and Gram-negative 
bacteria 
 
C
ef
pi
ro
m
e 4th gen, 
extended-
spectrum 
Cephalosp
orin 
Bacterial cell wall synthesis 
inhibition via PBPs affinity. 
Effective against Gram-
positive and Gram-negative 
bacteria. 
 
C
ef
to
bi
pr
o
le
 
5th gen, 
extended-
spectrum 
Cephalosp
orin 
Bacterial cell wall synthesis 
inhibition via PBPs affinity. It 
inhibits the PBP IIa in MRSA 
PBP IIx in penicillin-resistant 
S. pneumoniae. Effective 
against Gram-positive and 
Gram-negative bacteria.  
Legend 3: PBP: Penicillin Binding Proteins; MRSA: Methicillin-resistant Staphylococcus aureus 
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1.3.3. Carbapenems 
This class of antibiotics is structurally similar to the β-lactam antibiotics and is effective 
against Gram-negative rods and Gram-positive organisms. Initially, these antibiotics were 
used only to treat severe infections cause by Gram-negative pathogens that did not 
respond to treatment with other antibiotics.47 These antibiotics are effective inhibitors of 
the L,D-transpeptidase, which is resistant to the majority of β-lactams.48 This 
transpeptidase uses L-Lys-D-Ala (instead of D-Ala-D-Ala) as acyl donor in the cross-linking 
reaction of the peptidoglycan.49 
Its bicyclic structure is similar to penams but it does not possess the sulfur atom (the 2nd 
ring is not a thiazolidinic ring). 
Main difference between the two antibiotics presented in the next table relies on toxicity 
and resistance to peptidases.50   
Table 4: Spectrum, pharmacodynamics and chemical structures of several carbapenems. 
Class Name Type Mechanism of action 2D Structure 
C
a
rb
o
pe
n
em
s 
Im
ip
en
em
 
Broad-
spectrum 
Imipenem acts as an 
antimicrobial through the 
inhibition of cell wall 
synthesis of various gram-
positive and gram-negative 
bacteria. This inhibition of 
cell wall synthesis in gram-
negative bacteria is attained 
by binding to PBPs. In E. coli 
and selected strains of P. 
aeruginosa, imipenem has 
shown to have the highest 
affinity to PBP-2, PBP-1a, 
and PBP-1b. It results in the 
direct conversion of the 
individual cell to a 
spheroblast, which leads to 
rapid cell lysis and death 
without filament formation. It 
is inactivated by 
dihydropeptidases in the renal 
tubules. 
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M
er
o
pe
n
em
 
Broad-
spectrum 
The bactericidal activity of 
meropenem results from the 
inhibition of the cell wall 
synthesis. Meropenem readily 
penetrates the cell wall of 
most Gram-positive and 
Gram-negative bacteria to 
reach PBP targets. Its 
strongest affinities are toward 
PBPs 2, 3 and 4 of E. coli and 
P. aeruginosa; and PBPs 1, 2 
and 4 of S. aureus. It is not 
inactivated by 
dihydropeptidases and is less 
toxic than Imipenem.  
Legend 4: PBP: Penicillin Binding Proteins 
 
1.3.4. Monobactams 
Monobactams have a monocyclic “core” (only one β-lactam ring). The first drug of this 
class available was Aztreonam and it is only effective against Gram-negative aerobic 
bacteria without major toxic effects reported. Because of its activity spectrum it is 
recommended that initial treatment is performed with broader spectrum β-lactams.50, 51 
Table 5: Spectrum, pharmacodynamics and chemical structure of Aztreonam. 
Class Name Type Mechanism of action 2D Structure 
M
o
n
o
ba
ct
a
m
 
A
zt
re
o
n
a
m
 
β-
lactamase 
resistant 
The bactericidal action of 
aztreonam results from 
the inhibition of the third 
and last stage of bacterial 
cell wall synthesis due to 
a high affinity of 
aztreonam for PBP III.  
 
Legend 5: PBP: Penicillin Binding Proteins 
 
1.3.5. β-lactamase inhibitors  
These antibiotics are used to irreversibly inhibit serine dependent β-lactamases increasing 
the effect of other antibiotics that would be degraded to become more effective in 
treatment.52-54 
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Clavulanic acid, Sulbactam and Tazobactam (sulbactam and Tazobactam are penicillin 
sulfones) do not inhibit metallo-β-lactamases (MBLs). No efficient inhibition of MBLs is 
currently used in medical practice but progresses have been made in this way.52, 55  
Table 6: Spectrum, pharmacodynamics and chemical structures of the β-lactamase inhibitors: clavulanic acid and the 
penicillin sulfones sulbactam and tazobactam. 
Class Name Type Mechanism of action 2D Structure 
β
-
la
ct
a
m
a
se
 
in
hi
bi
to
rs
 
C
la
v
u
la
n
ic
 
a
ci
d 
β-
lactamase 
inhibitor 
Clavulanic acid 
competitively and 
irreversibly inhibits a wide 
variety of -lactamases, 
commonly found in 
microorganisms resistant to 
penicillins and 
cephalosporins. It results in a 
restoration of the 
antimicrobial activity of β-
lactam antibiotics against 
lactamase-secreting-resistant 
bacteria by inactivating β-
lactamase. 
 
Su
lb
a
ct
a
m
 
β-
lactamase 
inhibitor 
Sulbactam competitively and 
irreversibly inhibits a wide 
variety of β-lactamases, 
commonly found in 
microorganisms resistant to 
penicillins and 
cephalosporins. It results in a 
restoration of the 
antimicrobial activity of -
lactam antibiotics against 
lactamase-secreting-resistant 
bacteria by inactivating -
lactamase. It is used in 
combination with other β-
lactam antibiotics when the 
infectious agent shows 
resistance to clavulanic acid. 
 
Ta
zo
ba
ct
a
m
 
β-
lactamase 
inhibitor 
Tazobactam broadens the 
spectrum of piperacillin by 
making it effective against 
organisms that express β-
lactamase and would 
normally degrade 
piperacillin. 
 
Legend 6: PBP: Penicillin Binding Proteins 
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1.4. Computational chemistry 
The use of computational methods to predict results in molecular systems have increased 
due to its success, which has allowed important advances in Science that made 
experimentally, could mean years and high costs. 
Therefore, Computational Chemistry is a chemistry branch that allows the application of 
theoretical chemistry and physics, integrated in computer programs efficiently. It has as 
primary goal to obtain results that explain a given chemical problem.56 This  area of 
chemistry must be seen as an integrating part for scientific development. It should be in 
constant interaction with other areas as physical, inorganic and organic chemistry as well 
as molecular biology, in order to understand the structural and biological concepts that 
are essential to Science development. 
Nowadays theoretical chemistry allows, for example, the study of individual properties of 
the molecule (ionization energies, spectroscopic properties, molecular energy and 
structure, among others), and also resulting properties of the interaction between 
molecules (structural properties, molecular docking, geometry optimization of molecular 
complexes and protein structure predictions, to name just a few). 
Due to the amount of problems that computational chemistry is able to study, several 
methodologies were developed – ab initio method, semi-empirical (based on mechanical 
quantic’ laws and, in case of semi-empirical methods, empirical parameters are used in 
order to simplify calculus), density functional methods (electronic density calculus) and 
classical mechanics based methods (sub-atomic particles are not discriminated and, 
therefore, the atom is treated as a non-deformable spherical particle with a given radius 
(Van der Walls radius)).57, 58 
 
1.4.1. Molecular Mechanics 
The molecular systems simulations, with high number of atoms, by methods that 
consider subatomic particles, demand high computational capacity and can be potentially 
expensive due to the time required. Sometimes the computational resources and time 
Chapter I – Introduction 
Computational chemistry - Molecular Mechanics 
 
49 
involved are too high. To bypass this problem, classic mechanics have been of great 
importance to study large dimension proteins.56 
Molecular mechanics treats molecules as particles cluster (atom is the base unit of the 
system), with a given mass and bound together by coils, which allows the molecule to be 
study by classical mechanics laws (Newton’s Laws). This way, allows the study of the 
movement upon a force action without observing the bonds break due to the applied 
force. The total  energy of the system can be described through force fields 
parameterization.58 
 
1.4.1.1. Force fields 
A force field can be described as a mathematical function that permits to calculate the 
energy according to the position of the atom that constitute it, being necessary an 
ensemble of parameters that allows its application (due to the quantic character 
implied).57 
The energy of the system is composed by independent terms that describe not only the 
molecular distortion (related to intramolecular bounds) but also interactions with the 
surrounding atoms (VDW and electrostatic energy) and even crossed terms.57, 58 
Et = Estr + Ebend + Etor + EVDW + Eel + Ecross (1) 
The mathematical function represents the different terms necessary to calculate 
the total energy of the system (Et) being Estr the energy term that corresponds to the 
alteration in the atomic bond lengths, Eang the energy term associated to the angle bond 
variations, Etor the energy term for dihedral angle torsions, EVDW and Eel the terms for the 
interactions of Van der Walls and electrostatics and, finally, Ecross referent to crossed 
terms. 
 
 Energy due to bond length alteration 1.4.1.1.1.
The most accurate form to describe/calculate the energy associated with stretching or 
compression of the bond length is using the Morse potential function: 
  
50 
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  1 (2) 
Where  corresponds to the minimum value that the Morse potential can have,  is 
   !"#$%  (&'	is the force constant that the system has at equilibrium). 
Although this is more accurate than using a Hook potential function (harmonic potential), 
especially when applied to very high distances between two atoms, it demands longer 
computational times then Hook’s potential. Therefore Hook’s potential is commonly used 
in many force fields to describe bond lengths:57, 58 
() 	 &'*+  +
,- (3) 
To be able to reduce the computational time using the Harmonic potential the system 
should have lengths close to equilibrium so that the two potentials have similar values. 
 
Figure 7: Graphical representation of the Energy variation in Harmonic and Morse Potentials in relation with bond 
lengths. 
 
 Energy due to bending 1.4.1.1.2.
Like the previously described “bond length alteration” term, the energy related to the 
increase or decrease of an angle can be described with Harmonical potential with 
reasonable accuracy (it has limitations when there are multiple equilibrium values or 
when working with geometries that are very different compared to equilibrium).57, 58 
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. 	 &.*/  /
,- (4) 
In this equation θ  and θ12  represent the angle between atoms and the angle at 
equilibrium and K4 is the force constant associated with bending. 
 
Figure 8: Graphical representation of the Energy variation in Harmonic Potential in relation to bond angles. 
 
 Energy due to torsion 1.4.1.1.3.
Torsional energy can be obtained estimating the energy variation when a bond rotates. 
To perform this calculation the dihedral angle is analyzed. This angle varies within [0°, 
360°] or [-180°, 180°]. Unlike  .  and (), if / rotates 360° energy returns to the 
original value.57, 58 
A mathematical expression to calculate this energy can be: 
5 	 &561 7 cos	;<  => (5) 
Where &5 is the constant related to the minimum energy necessary to rotate a bond, < is 
the dihedral angle, ; represents the number of minimums that the function presets when 
rotated 360° (multiplicity) and =	represents where the angle has its minimum energy. 
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Figure 9: Graphical representation of the Energy variation in relation to bond torsion angles. 
 
 Van der Walls energy 1.4.1.1.4.
Van der Walls energy describes the attraction or repulsion of nonbonded atoms and it’s 
not taken into account by the electrostatic energy and therefore isn’t affected by atoms 
charges.  
Van der Walls force and the corresponding energy are inversely proportional to distance. 
The maximum value when the distance between to atoms equals the sum of the van der 
Waals radii and as the distance in between increases, Van der Walls force will tend 
towards 0. If the atoms are brought closer than distance for Van der Walls energy 
maximum value, a very repulsive interaction occurs because the electron cloud overlap.57, 
58 
The energy expression for these forces can be represented by the mathematical 
expression:57 
?@A, C  4EFG HIJKLKLM
 	IJKLKLM
NO (6) 
This equation represents the Lennard-Jones potential for a pair of atoms A, C and it has 
an attractive term, 4EFG IJKLKLM

and a repulsive term 4EFG IJKLKLM
N
. 4EFG corresponds to 
the minimum energy of the function for Lennard-Jones potential and PFG is the sum of the 
Van der Walls radii. 
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 Electrostatic energy 1.4.1.1.5.
Electrostatic energy describes interactions of atoms that are not directly bonded that are 
a result of point charges. These interactions can be described with Coulomb’s law 
mathematically represented by the equation:57, 58 


A, C  Q
 R,K	,LRS  (7) 
Where r is the distance between the atoms and TF	TG the point charges of the atoms. Q
 is 
the Coulomb’s constant (or the Coulomb force constant) and can also be represented by: 
Q
  UVW (8) 
 
Figure 10: Graphical representation of the Energy variation due to VDW interactions (repulsive) and due to 
electrostatic interactions (Attractive). 
 
 Cross terms energy 1.4.1.1.6.
With the inclusion of these terms in molecular mechanics force fields, it becomes possible 
to establish a correlation between different terms of the force field like bond length and 
bond angle, bond length and torsion, among others.58 The downfall of adding this term is 
that it becomes much more computationally expensive.   
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1.4.1.2. Common force fields 
When performing biological systems MD simulation, the most commonly used force fields 
are AMBER (Assisted Model Building with Energy Refinement), which is used mainly for 
proteins and nucleic acids, and CHARMM (Chemistry at HARvard Macromolecular 
Mechanics), which can be used in simulations of systems with variable size and 
complexity.58-60 
 Force fields that give parameters for all the atoms in the system (all atom type) were 
developed with the downside of being more time consuming. The mathematical function 
has been described by Case D. et al.59, and is represented by equation 9: 
  
 (9) 
 
The terms that compose the mathematical function of AMBER force field have 
been described in section 1.4.1.1. 
CHARMM is also a force field that gives parameters for all the atoms (all atom 
type). It has been described by Brooks C. et al.60, and is represented by the equation 10: 
 
 (10) 
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1.4.2. Molecular Dynamics 
Molecular dynamics (MD) have been applied for the past three decades to study 
macromolecules with biological interest. The first biomolecule of interest to be studied 
using MD was bovine pancreatic tripsyn inhibitor (BPTI). This publication had a major role 
to the evolution of the general understanding of protein structure. As up to 1975, 
proteins were seen as rigid body structures.61 Nonetheless, it was initially described in 
1959 by Alder and in 1964 by Rahman.61-63 These methods calculate, with detail, 
individual motions of particles as a function of time and can be used to address some 
questions about a system such as investigating the structure, thermodynamic proprieties 
and others.64 Some structural motions investigated by MD are local motions: atomic 
fluctuations, up to large scale motions like dissociation/association of subunits. 
Given the complexity of the systems with biological interest it becomes clear that the 
evolution of the computational methodologies was made alongside the evolution of 
computers and other related hardware. The increasing power of computers have led to a 
proportional increase in the complexity of the calculus inherent to MDs, allowing bigger 
molecules to be studied, more detailed studies and even complexes. There also some 
noticeable disadvantages: (i) the need to parameterize all the intervenient species, (ii) not 
be able to study systems with breakage or formation of new bonds and (iii) not being as 
accurate as ab initio or DFT 
Molecular dynamics simulations allow the study of the macroscopic properties of a 
system (state functions), generating information at a microscopic level (atoms positions 
and velocities). Examples of state functions used to characterize the macrostate of the 
system are volume (V), number of particles (N), pressure (P), temperature (T) and 
others.65 
In order to define the thermodynamic state of a system, α+2 state functions need to be 
specified, where α is the number of components of the system. All the remaining 
proprieties can be calculated through the thermodynamic fundamental laws. 
To any macrostate corresponds an infinite number of microstates therefore the ensemble 
of microstates of the system will have the same value for α+2 state functions (an 
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ensemble has different microscopic characteristics but similar macroscopic 
thermodynamic state).65 
 
Table 7: Constant state functions in the most common ensembles 
Ensemble Constant state functions 
Microcanonical ensemble (NVE) number of atoms, N, volume, V, energy, E 
Canonical Ensemble (NVT) number of atoms, N, volume, V, temperature, T 
Isobaric-Isothermal Ensemble (NPT) number of atoms, N, pressure, P, temperature, T 
Grand canonical Ensemble (mVT) chemical potential, m, volume, V, temperature, T 
 
Molecular dynamic simulations generate successive microstates (trajectory) solving 
algorithms based on Newton’s second law or equation of motion, which allows the 
calculation of the trajectory for all the particles of the system. 
XYZ  	 [\]]]^ 	_%`K  (11) 
The position of a particle can be obtained for t0 + Δt solving equation 12: 
PYZ 7 Δt  PYZ 7 cYZ. Δt 7	e\]]]]^ 	_% . Δt (12) 
The velocity of a particle can be estimated for t0 + Δt solving equation 13: 
cYZ 7 Δt  cYZ 7 Xf]]]^ 	Z. Δt (13) 
Where PY is the initial position of the particle, cY is the velocity and Δt is the time step. Δt 
must be small enough so that the force that is applied to the particle remains the same 
from t0 to t0 + Δt – the force that acts on a particle is dependent of all the particles 
position surrounding the first so during Δt changes on the position of surrounding 
particles should be small enough that the force remains constant. 
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With the wide variety of subjects that can be studied using MD it becomes clear that the 
time of simulation and time step are two critical aspects of the simulation. It should be 
chosen accordingly to the type of system and movement to be investigated. 
Choosing the right time step becomes critical. If it is too small the computational cost will 
be too high, and if it is not small enough the inaccuracy of the integration of the motion 
equations will increase. 
A common method to define the integration step is to choose one that is one order 
smaller than the time associated with the fastest movement in the system (in 
biomolecular systems this is usually the time scale for bond-stretching of bonds with 
hydrogen atoms – 10fs). These high frequency movements are rarely relevant and an 
integration step this small would make the simulation more expensive. A common 
solution to this problem is to restrain hydrogen bonds to their equilibrium length, 
allowing a longer integration step to be used (2fs instead of 1fs). A popular method to 
make constrains is to use the SHAKE algorithm. 66 
Another important aspect when performing MD simulations is the temperature. The 
equations used with this methodology are conservative so it is usually necessary to 
maintain the temperature of the system constant – a thermostat is applied.67 
Different types of thermostats were developed being the most common Nosé-Hoover68, 
Berendsen69 and Langevin thermostats70, 71.   
When a thermostat is applied, the integration of the motion equations will take into 
account the friction coefficient,	g, as an additional acceleration, either positive or 
negative, for all the particles in the system.67 
The additional acceleration is obtained by: 
gZ. cYZ (14) 
where gZ is calculated with the differential equation: 
h_
_  ijS k
i
lmn  1o (15) 
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Where pl  is the temporal constant, p is the initial temperature and q
r_ the temperature 
to which the system converges. 
1.4.2.1.  Periodic boundary conditions 
In the MD simulations, systems under simulation have an atom count within the 
thousands which are contained in simulation cell. Simulation cells can be cubic, 
octahedral or parallelepiped and can also present other shapes, although less used, 
because of the additional complexity that those would cause. 
With this type of approach to the simulation the problem of surface effects arises. 
Particles close to the walls of the simulation cell are subject to a different set of 
interactions when compared to those in the center of the cell. 
One way to overcome this problem is creating periodic boundary conditions. By doing so, 
it is considered that the simulation cell is the central cell of a network made with an 
infinite number of its replicas. The motion equations are numerically solved only for the 
particles in the central cell and the particles in the replica cells will mimetize the motions 
of the first particles- image particles. 
The calculation of the intermolecular interactions has to be an approximation because 
they can only be calculated for a finite number of particles. To perform this calculus there 
are two methods: the minimum image or the spherical cut methods. Both have as base 
principle to ignore interactions above a certain interatomic distance. 
When using the minimum image method, it is centered on each atom a cell with same 
size and shape as the simulation cell and if the spherical cut method is applied it is 
centered on each atom a sphere with pre-determined radii. All the atoms within this 
“atom-centered” cells are taken into account for the calculus of the intermolecular 
interactions and all the remaining are excluded. It is of great importance to choose a cut-
off radii or cell dimension large enough so that the atom that is defined as the center to 
have low energy interactions with its images. Otherwise, non-physical effects might result 
from these methods. When working with a system having as its components a protein 
and explicit water, the size of the simulation cell shall be, at least, the size of the protein 
plus twice the cut-off length that is considered for the calculus the interactions. 
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Intermolecular interactions can be separated in short or long range interactions. The first 
are usually described by Lennard-Jones terms and the latter by Coulomb potential. To 
calculate the interaction energy a cut-of-radii needs to be chosen, which is not a problem 
for short range interactions because for a computational acceptable radii the interaction 
energy is very low. Therefore does not affect the final result (a corrective term is added to 
compensate the energy not taken into account for the calculus). Unlike these, Columbic 
interactions would need a large cut-off radii in order to make the remaining interactions 
despicable. If it is set to a distance that is too short it will produce considerable 
distortions. 
 
Figure 11: Schematic representation of the Periodic Boundary Conditions. In the center is the simulation cell, 
surrounded by replica cells that reproduce the movement of the particles in the center cell. 
 
1.4.2.2. Particle Mesh-Ewald method (PME) 
The Particle Mesh-Ewald method72 was developed by theoretical physics, which had as 
foundation for their work the Ewald summation73, before computers were used. 
However, it started to be widely used with the development of technology and with it 
computers, allowing the simulation of systems with electrostatic interactions. PME 
method introduces two changes in the system.73 The first, every punctual charge is 
neutralized, at long distances, with the addition of a spherical charge cloud equal in 
magnitude to the point charge with density given by a Gaussian function centered on the 
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point charge. After this, the interactions of the system can be treated as discussed 
previously – simple cut-off. The second change consists on canceling the effect of the 
introduction of the first charges adding a second set of opposite Gaussian charges 
(counter-ions).74, 75 The potential caused by the charges added can be obtained with 
Poisson equation and calculated a Fourier series. 
After the calculation of the Ewald summation it is necessary to subtract the energy of self-
interaction. This constant can be calculated.  
 
1.4.3. Molecular docking 
With the development of new techniques that allowed to obtain macromolecules 3D 
structures (like crystallography techniques, for example), the number of macromolecules 
of interest with known crystallographic structures has been increasing (in the order of 
tens of thousands in the RCSB-PDB).16 Despite all the advances in this type of techniques, 
to crystalize protein – protein and protein – ligand complexes is still slow and expensive. 
To overcome this problem, some methods as molecular docking were developed. In 
molecular docking the goal is to understand and predict the association of from a 
structural and energetic point of view. 
According to the study object, the methodologies may vary and its choice may influence 
considerably the outcome of the study in question. The critical steps to take into account 
in these methodologies are the choice of the flexibility of the molecules, the searching 
and scoring function algorithm. In molecular docking is possible to divide methodologies 
in protein – protein or protein – ligand docking. 
 
1.4.3.1. Protein – protein  
In this type of methodology the goal is to predict the structure of a 2 proteins complex 
(the structure of both exists previously) by complementarity of shape, charge or energy 
between them. 
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1.4.3.2. Protein – ligand 
This methodology tries to predict most favorable configuration of the ligand (small 
molecule) when bounded to the protein and to evaluate this bound intensity. This 
method allows the evaluation of several of the orientations of the ligand as well as their 
different conformations (it is possible to analyze all the degrees of freedom of the ligand). 
The different complexes obtained in this type of docking are evaluated according to the 
orientation and conformation of the ligand, bounds energy and, in some cases, bound 
spot (active centers of already studied enzymes). 
 
1.4.3.3. Docking algorithms  
 Searching algorithms 1.4.3.3.1.
Despite apparent sensibility in docking methodologies, it is necessary to consider 
important aspects in this type of work. In a molecular docking methodology between 
macromolecules and ligands the complexity is very high due to the degrees of freedom 
present in the two molecules, which leads to high computational resources necessity. All 
the software’s initiate by a looking of the best fitted pose for the complex under study: 
the searching part. 
 
1.4.3.3.1.1. Rigid algorithms 
By using rigid algorithms, both molecules (receptor and ligand) will be treated as rigid. 
Consequentially, the docking process will be very quick compared to the docking if both 
structures were treated as flexible. With the development of technology, the calculus 
speed increased considerably allowing this type of algorithm to be progressively replaced 
by others that treat the ligand, and sometimes also the receptor, as flexible. This 
preference is due to the fact that, by limiting the molecules freedom degrees, it is also 
blocked the opportunity to find the most appropriated conformation.76-78 
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1.4.3.3.1.2. Semi – flexible algorithms 
In this type of algorithm the receptor is considered rigid but the ligand is now treated as a 
flexible molecule. There are two distinct methods that consider the ligand as flexible: the 
systematic method and the random method. 
 
1.4.3.3.1.2.1. Systematic method 
Algorithms of systematic search try to use all the degrees of freedom of the molecule. 
This can be divided in search methods of:79 
    Conformation – all the bounds that may suffer rotation twirl 360° to form all ligand’s 
possible combinations of the ligands, which results in accentuated increase the number of 
combinations. 
     Fragmentation – initial docking may come from ligands fragments in the active spot 
followed by covalent bond between fragments or may be done with the rigid part of the 
ligand with posterior addition of the flexible zones. 
     Data base – libraries with already generated conformations are used to count all 
possible conformations due to the flexibility of the ligand.80 
 
1.4.3.3.1.2.2.  Random methods 
In random methods the structure of the protein where the docking is made is submitted 
to random variations of the conformation of the ligand being the final result accepted or 
not. There are 3 types of algorithms for this method:79 
    Monte Carlo – based on an energy function, not needing additional information.81 
    Genetic Algorithm (GA) – application of algorithms based on natural selection and 
genetic concepts in docking. This method has an initial population, unlike other methods, 
composed by several conformations of the ligand towards the protein. This allows the 
possibility to explore different regions of the search space leading to enhanced 
performance. 82 
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One of the great advantages using this type of algorithm is that it allows a comprehensive 
design of the algorithm taking into account the type of problem to be solved, which is 
why this type of algorithms can be used for a variety of problems and not only docking. 
This can be done with the definition of some essential components and procedures. 
Genetic algorithms will encode the input parameters into solutions or strings where each 
string represents a chromosome (candidate solution in initial population). To select the 
better candidates to lead to next generation a fitness function is applied, measuring the 
quality of the candidate solutions. The fitness function to be applied can vary. It can be 
obtained with a mathematical function or a more complex computer simulation. It is also 
possible to select the best candidates from the initial population with a more subjective 
evaluation. 
To further evolve the obtained individuals a series of genetic operations can take place 
(crossover and mutation) and also in this step there is several possibilities to adjust the 
genetic operators to better suit the problem to be solved (type of crossover and 
mutations). 
Although genetic algorithms can vary greatly a general procedure can be appointed: 
Step 1. Origin – Generate the initial population (P0) 
Step 2. Fitness Evaluation and Selection – Selection of the best individuals (P1) 
from P0 
Step 3. Crossover – Apply crossover to population P1 to generate a offsring O0 
Step 4. Mutation – Mutate O0  to obtain O1  
Step 5. Replacement – Replace P0 with O1 
Step 6. Termination – Select final population/solutions 
    Tabu search – with this method the docking process is stopped in already studied 
receptor areas promoting, this way, new docking regions. 
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1.4.3.3.1.3. Flexible algorithms 
    This type of algorithm is used when the receptor’s flexibility (by increase to the ligand) 
cannot be rejected. Some systems may suffer alteration in their structure after the ligand 
bonding such as near side chains rearrangement. 
To make this kind of methods more viable from a programing point of view, the molecule 
target’s partial flexibility is considered. In this type of methodology it can be use 
molecular dynamics and Monte Carlo methods (a more powerful but not so used 
technique due to the amount of time required), rotamers libraries, protein grids and 
flexible receptor modulation.  
 Scoring functions 1.4.3.3.2.
    This type of functions allows the evaluation and classification of ligand conformations 
and the differentiation of molecules that bound to the target molecule or not.79 A scoring 
function that would allow the proper evaluation of all bond aspects would be very 
demanding from a programing point of view. For that reason some simplifications are 
made in order to reduce its complexity.83 Scoring functions can be divided into three 
categories: based on force fields, of empirical bases or based on knowledge: 
 
1.4.3.3.2.1. Based on force fields 
    These functions are based on the application of force fields that quantify the energy’s 
interaction between receptor and ligand and the ligand’s internal energy. For this 
quantification VDW and electrostatic energy are considered.83, 84 
 
1.4.3.3.2.2. Based on empirical data 
    This type of function is created to reproduce experimental data and is based on the 
possibility of bond energies being able to be obtained, approximately, by the sum of some 
unrelated individual terms.83 
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1.4.3.3.2.3. Based on knowledge 
    In this case general principles and rules are followed so that certain structures obtained 
experimentally are reproduced. These methods are based on atom-atom interaction 
potentials that are defined by the frequency of different atom-atom interactions 
observed on known data base of complexes protein – ligand structure.79 
This type of scoring functions, although fast, either neglect solvation or approximate the 
effect from solvation with relative simple models (e.g. empirically derived group additive 
desolvation parameters). 
In recent years, there have been reports on a number of methods that use explicit water 
molecules in the system, to calculate solvent-dependent energies more accurately. 
Thermodynamic integration (TI), Free Energy Perturbation (FEP) and Grand Canonical 
Monte Carlo (GCMC) are very accurate and rigorous methods but also extremely time 
consuming (great statistical sampling must be carried out) which prevents their use in 
docking algorithms.85 
Scoring functions based on continuum solvent models offer a good compromise between 
using explicit water molecules and neglect the contribution of interactions with solvent. 
All atom methods have been developed using continuum solvent namely MM-PBSA and 
MM-GBSA. These methods treat the solvent as a high dielectric continuum field which 
enables the approximation of the energies of desolvation to move charged atoms into 
and out of the dielectric field of the protein and ligand in a time efficient manner.85 
 
1.4.4. Autodock 
    Autodock is free use software for noncommercial purposes and is particularly effective 
in protein – ligand docking.86 It is one of the most quoted software by the scientific 
community and is currently used on the FightAIDS@Home (Olson Laboratory). This 
software is composed by two main programs: 
    AutoGrid: allows the calculation of the grids that describe the target protein 
    AutoDock: effects the ligand docking with pre-calculated grids assembly 
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    In the AutoGrid the protein is placed in a three dimensional grid and, in each grid point 
is placed a probe that corresponds to each atom found in the ligand. The 
dispersion/repulsion energies, and when necessary also energies associated with 
hydrogen bridges, are calculated all the atoms the atoms of the receptor until 8Å of each 
grid point.86 The resulting data are saved in grid files, separately. The AutoDock uses a 
semi-empirical force field to calculate the associated energies to the protein(P) – ligand(L) 
bond. The bonding free energy is estimated in two steps: first the two molecules’ 
transition between their conformation when bonded and not bonded is energetically 
evaluated, and secondly the intermolecular energies associated with the complex 
formation process is evaluated – equation 16. It is also estimated the entropy variation 
associated to this process (∆Sconf).87 
 
∆t	  Iu v  v+AwXxy  u v  v;ãy	+AwXxyM 7	Iu {  {+AwXxy  u {  {;ãy	+AwXxyM
7 Iu {  v+AwXxy  u {  v;ãy	+AwXxy 7 ∆|}y;~M 
 (16) 
 
1.4.5. Free energy calculations 
Free energy is a thermodynamic value that allows the understanding of how biochemical 
molecules associate and react.88 It is usually expressed as Helmholtz function (F) or Gibbs 
function (G). These two functions are applied for different ensembles where Helmholtz 
function is used for NVT and Gibbs function is more suited for NPT ensembles. 
In order to obtain a good estimation of absolute free energy all the possible states for the 
system should be sampled, which is not viable due to the amount of calculus. Instead, the 
difference of free energy between two states is calculated and in result we have the 
probability of finding one of them and not the other. 
For the past decades, several methodologies have been developed to calculate free 
energy using MD. These methods allow us to predict protein stability, drug affinity to a 
target, among other aspects. Among these methods are TI, FEP and MM-PBSA and the 
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choice will take in consideration several factors (i.e. time). TI and FEP are the most 
rigorous but demand long simulation times.89 In these methods a gradual transformation 
between two states of interest occurs. Although MM-PBSA is less rigorous it is the most 
often used as it is less time consuming. In any of these methods it is necessary to carefully 
choose time of simulation, force field, among others because these will affect the 
accuracy of the calculus. 
 
1.4.5.1. Molecular Mechanics/Poisson-Boltzman Surface Area 
In MM-PBSA the MD trajectory is analyzed and a continuous solvent model is used.90, 91 
Free energy is calculated using equation 17: 
t   7 t  q| (17) 
EMM is the energy from molecular mechanics (includes all the parameters discussed 
previously for molecular mechanics), GPBSA is the solvation free energy estimated by the 
numerical resolution of Poisson Boltzamn equation. PB equation describes the 
electrostatic interaction between molecules in ionic solutions and is often used in MD and 
related fields because it can be used to approximate the effects of solvent on structures 
of biomolecules – implicit solvent.90 PB equation can be represented as in equation 18: 
4P = ∇EP∇P − Q′P (18) 
Where P is the electrostatic potential, ε(r) is the dielectric constant, ρ(r) the charge 
desnsity and k’ is the inverse of the Debye-Huckel lengh. 
GPBSA and EMM are obtained by calculating the average of several geometries from the MD 
simulation. -TSMM refers to the solute entropy and often is not taken into account because 
it is considered to have the same value for molecules with similar dimensions. 
Delphi is a software that calculates electrostatic potential and energies in systems of 
biomolecules by numerically solving the Poisson-Boltzman equation. In this software the 
first step is to overlap a cubic shaped grill to both solvent and solute. Values for 
electrostatic potential, charge density, dielectric constant and ionic force are calculated 
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for each point of the grill. Because atomic charges usually are not coincident with the grill 
points, this is allotted to the nearest eight points.  
The boundary between solute and solvent is defined by the molecular surface and all the 
grill points that are placed out of it have dielectric values and ionic force assigned of the 
solvent. The points within the grill have dielectric constant for solute assigned.  
After this, Poisson-Boltzman equation is solved for each grill point until convergence is 
achieved. 
The calculus of the electrostatic component of the free solvation energy is obtained when 
a solute is transferred from a low dielectric constant to a high dielectric constant 
condition causing a variation is electrostatic energy. This can be obtained through the 
resolution of equation 19:91 
∆t  ∑TFFU  F (19) 
In this equation “q” represents punctual charges of the solute. 
The non-electrostatic contributions for free solvation energy have greater importance 
when working with non-charged or low polarity solutes and are obtained with the 
equation 20: 
Δt  = 7  (20) 
Where A is the solvent accessible area and γ and b are constants obtained from 
experimental data – γ is 0,00542 kcal Å-2 mol-1 and b 0,92 kcal mol-1, 
 
1.4.5.2. Protein-Ligand binding affinity 
To calculate ligand binding affinity, it is necessary to calculate energies for complex, 
receptor and ligand for the structures that were obtained from the MD simulation In 
continuum solvent. This calculus follows the equation:92 
∆t`

  *t`
r-  *t

_-  tFe (21) 
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Where ΔGmolecule corresponds to the binding free energy and the other terms are the 
energy associated with the complex, receptor and ligand. 
Internal energy, electrostatic energy and Van der Walls energy are obtained using the 
force field. The external dielectric constant is solvent-dependent but the internal 
dielectric constant cannot be assigned universally because any protein is highly complex. 
Therefore, each case should be analyzed carefully and this constant should be adjust for 
the specific system being studied.  
 
1.4.6. Protein-ligand interface 
One important field of molecular biology is the discovery and understanding of all 
interactions between molecules especially those with highly relevant biologic role. 
Protein-ligand interfaces are of noticeable relevance when studying enzymes given the 
relevance of this type of proteins for many biological mechanisms which include disease 
related mechanism such as drug-target interaction or drug resistance mechanism. 
Protein-ligand interfaces are usually very complex and have a high number of residues 
but only a few participate in the protein-ligand interaction.93 It becomes clear that the 
study of these interfaces becomes necessary to the better understanding of the structural 
and energetic features of interfacial residues. More knowledge on this field can help to 
understand the biologic role and activity of the protein and/or ligand under study. 
The forces that influence the formation and stabilization of these complexes (protein-
ligand) can vary due to the structure of the ligand itself and the type of aminoacid 
residues that form the interface and even others that at a first glance might look of less 
relevance. The residues in the interface can interact with the ligand via hydrophobic 
interactions, hydrogen bonds, salt bridges, electrostatic forces and VDW forces and π-
interactions. Covalent bonds tend to be minor contributors to molecular recognition and 
if present they are often irreversible due to the bond strength. 94, 95  
Most interfaces have a high number of conserved residues and form a high 
complementary pocket, in shape and hydrophobicity and hidrophilicity regions between 
protein and ligand.96 
  
70 
The type of aminoacid residue becomes clearly relevant to the interactions in the 
interface but is important to refer that the nature of the ligand as also high impact on the 
interface (different ligands having similar M.W. and general structure might behave in a 
different manner due to the existence or not of double or triple bonds and different 
position of polar atoms).94 
 
1.4.7. Alanine Scanning Mutagenesis (ASM)   
Although protein-ligand interfaces are large and complex they can all be characterized by 
size, shape and complementary and single residues can be appointed as being responsible 
for the majority contribution for binding energy – Hot-Spots (HS).92, 97 
To define HS of the interface ASM can be performed in two different approaches: 
computational analyses or a more practical analysis. The practical approach can be 
performed to provide empirical data but it has major disadvantages associated with not 
only the time necessary to perform the experiment but also the high cost inherent to this. 
Unlike the computational method where, in general, there is only the need to mutate in 
silico the residue to be studied, removing the side-chain past the β-carbon and have a 
single MD simulation, doing this in bench work involves mutation of the gene of interest, 
expression of the protein, isolation and sometimes refolding. These methods are all cost 
and time consuming and are prone to practical complications that can arise. 
Thus, ASM can infer the role of the side-chain and the energetic contributions for binding 
energy. To analyze the contribution of each side chain binding free energy is estimated as 
in equation 22:4 
∆∆t'FF  ∆t'FF`_e_  ∆t'FF@F	_
  (22) 
When after the alanine mutation cause an increase of binding free energy of 2kcal/mol or 
more, that given residue is considered an HS and when the increase reaches 4kcal/mol or 
higher, the residue has a major role in binding. However these are unusual.98 Glycine 
could also be used but would introduce flexibility in the protein backbone.94 The problem 
with this methodology is that the contribution of the residues backbone cannot be 
studied in this manner, which might lead to erroneous results since the contributions that 
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it has for the interface is, in average, one fifth of the interface area and it contributes with 
almost two thirds of the hydrogen bonds.99 
Systematic analyses of hotspots have shown that they have a distinctive aminoacid 
composition – tyrosine (12.3%), tryptophan (21.0%), arginine (13.3%) and are usually 
conserved residues.95, 98, 100 Aromatic residues clearly have high incidence as HS as they 
can contribute with cation-π interactions, having a large hydrophobic surface and 
capability to form H-bonds. Arginine can form up to 5 H-bonds and a salt bridge 
(guanidinium group is positively charged).94, 101  
Systematic studies of HS have shown propensity for HS to be inaccessible to the solvent, 
shielded by other residues in an O-ring structure.95 This lead to the O-ring theory, which 
states that residue with high impact on binding free energy are protected from bulk 
solvent. 
When performing the mutation for alanine the effect of the side chain removal over the 
orientation of surrounding residues is not treated explicitly in the single trajectory. To 
overcome this downfall, it is mimicked by the internal dielectric constant that increases 
with the polarity of the mutated residues. It allows for a better prediction of HS when 
charged residues and highly polar residues are involved. Previously, the relative binding 
free energy calculated for charged residues was an important limitation to ASM.92 It was 
demonstrated that instead of a single dielectric constant, different dielectric constants 
should be used to obtain a good accuracy: 2 for non-polar residues, 3 for polar residues 
and 4 for charged residues. Although these constants have led to great results, 
adjustments might be needed due to the extreme complexity and variation between 
protein interfaces.92 
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1.5. Objectives 
1.5.1. Computational studies 
In this work the aim was to characterize two TEM variants (TEM-180 and TEM201) both 
structurally and in terms of their activity against antibiotics. Since no 3D structure is 
available, they were constructed by in silico mutation of TEM-1 structure. To analyze their 
activity against antibiotics Molecular Docking was performed and complexes structures 
analyzed. To accomplish these objectives more specific objectives were appointed: 
a) Verify which are the mutations present in the proteins of interest (variants TEM-
201 and TEM-180) by alignment with the wild-type protein (TEM-1) 
b) Construct the enzymes TEM-201 and TEM-180 by in sillico mutation of TEM-1 
c) Verify if there are any differences in the conformation of important residues in the 
catalytic process of the enzymes 
d) Perform molecular docking for the wild-type protein, TEM-201 and TEM-180 with 
a data base with different antibiotics 
e) Justify any alterations in the hydrolysis ability of different ligands based on the 
determined structural and energetic characteristics of the different complexes 
 
1.5.2. Experimental studies 
To characterize the biologic activity of TEM-180 and TEM-201 clones, producing these 
enzymes, were subjected to growth with several antibiotics. In order to achieve this, a 
series of specific objectives were appointed: 
a) Synthetize high expression vectors with the sequences of TEM-201 and 
TEM-180 
b) Clone E. coli 25922 with the synthetized vector 
c) Test biological resistance of the cloned E. coli against several antibiotics 
d) Compare results obtained in the different methodologies concerning the 
antibiotics bonds    
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2. Theoretical Methods 
2.1. Structure preparation 
To determine the mutations of the TEM variants an alignment of the sequences of TEM-
180, TEM-201 and TEM-1 was performed using ClustalW.102 TEM-180 has the mutations: 
I84V, V184A, M272T and D273E, and TEM-201 has the mutations: L30V, I84V, V184A and 
S268G. 
The structures of the TEM variants (TEM-180 and 201) were obtained by in silico 
mutations of TEM-1 (PDB ID: 1ZG416) and protonation states were assigned using 
Schrödinger Software, LLC103. 
 
2.2. Molecular Dynamics simulation 
The protein structures obtained in the previous step were was stabilized and refined by 
MD simulation with the modified Cornell force field, by Duan et al. – ff03.104, 105 The MD 
simulation was carried out in explicit solvent with the TIP3P106 water model using the 
AMBER9 program59, First, the water was equilibrated in the presence of the fixed complex 
(25 ps), then only the side chains were relaxed (200 ps) - minimization, and finally a 
production run of 16 ns was done for the system. During the initial 2 ns of the production 
run temperature was increased from 0 to 300K (ensemble NVT) followed by 14 ns of 
production at constant 300K (ensemble NPT). In the restrained simulations, the atoms 
were subjected to a harmonic restraining force of 10 kJ mol−1.nm−2. In all MD simulations, 
the bond lengths involving hydrogens were constrained using the SHAKE algorithm66, the 
equations of motion were integrated with a 2 fs time step, and the Langevin algorithm70, 
71 was used to regulate the temperature of the system. All of the crystallographic waters 
were removed from the structure subjected to the MD simulation. Periodic boundary 
conditions were applied using PME72, 73 to treat long-range electrostatic interactions, and 
counter-ions were added to keep the whole system neutral. We used a 10-Å separation 
between each edge of the box and the closest solute atom to minimize electrostatic 
interactions between periodic images of the solute. We calculated Root-Mean-Square-
Deviation (RMSD) profiles using the average structure as reference. For each of the last 6 
nanosecond of the MD simulation, the structure with lowest RMSD was selected for the 
following procedures.  
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2.3. Molecular Docking 
Protein-ligand docking was performed using the six microstates ensemble from the 
protein MD simulation as targets and several antibiotics: Penams or penicillins 
(Amoxicillin, Ampicillin, Benzylpenicillin or Penicillin G, Phenoxymethylpenicillin or 
Penicillin V, Cloxacillin and Methicillin), Carbapenems (Imipenem and Meropenem), 
Cephems or Cephalosporins (Cefoxitine, Cefotaxime, Cepholosporin C and Cefpirome) and 
β-lactamase inhibitors (Clavulanic acid, Sulbactam and Tazobatcam) selected, according 
to their clinical relevance. Their structures were obtained from PubChem Compound.107 
The AutoDock 4.2 package86 was used for the entire docking procedure. An energy grid of 
46 Å × 40 Å × 40 Å in dimension, with a 0.375-Å grid spacing (the center of the Grid Box 
and dimension were previously tested) were generated with the program AutoGrid. 
Gasteiger charges were assigned to the ligand atoms. AutoDock 4 was used to evaluate 
ligand-binding energies over the conformational search space using the Genetic 
Algorithm-local search method. Default docking parameters were used with the following 
exceptions: ga-pop-size, 200; ga-num-evals, 10,000,000; and ga-run, 50. The structural 
poses that resulted from the docking were analyzed taking into account several 
parameters: (i) the binding energy should be negative; (ii) the complexes should have 
either low energy and form clusters with a higher number of complexes; (iii) the β-lactam 
ring should be on the more internal part of the catalytic pocket and, if possible, facing the 
catalytic Ser70; and (iv) the complexes should have a high number of interactions 
(protein-ligand). To this purpose interaction maps of the complexes were made for the 
various solutions with the LIGPLOT package108. 
 
2.4. Molecular Dynamics simulation of protein-ligand complexes 
The final complexes obtained from molecular docking were stabilized and refined with 
MD simulations following the procedure described in section 2.2. 
To obtain the parameters for the different ligands, partial atomic charges were derived 
with standard HF/6–31G* RESP109 methodology using the program Antechamber 
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implemented in the Amber package59. Atom types and missing force-field parameters of 
the ligands were assigned from with GAFF force field.110 
 
2.5. Structural analysis 
RMSDs and Root-Mean-Square-Fluctuations (RMSFs) of the protein backbone and the 
various ligands were calculated for all the MD simulations in order to investigate their 
stability. For a detail study of the binding interface, significant residues were selected: 
Met69, Ser70, Lys73, Tyr105, Ser130, Asn132, Glu166, Asn170, Val216, Lys234, Ser235, 
Glu239, Arg244 and Arg275. This selection took into account the literature2, 11, 29 and the 
manual inspection of the binding site to ensure that crucial residues were selected. For 
these residues, RMSF and B-factors were calculated to investigate the deviation of these 
compared to a reference position. The environment around the same residues was 
carefully characterized. For this step, all residues and water molecules within 5 Å of each 
interfacial residue were selected and their occupancy was estimated. We have also 
analyzed the radial distribution function, g(r) or RDF, as well as, the average number of 
waters within a given distance, of all interfacial residues. G(r) gives the probability of 
finding an atom at distance r from another atom, in relation to the probability expected 
for a bulk solvent distribution at the same density. It was calculated by compiling a 
histogram with a spacing of 0.02 and a range of 8 Å. These two procedures, as well as, the 
visual inspection of the MD simulations were performed with the VMD package and 
tailor-made scripts.111 Crucial inter-atomic distances for the enzyme catalytic activity and 
enzymatic inhibition were measured for all the MD simulations. All structural 
representations were made by the PYMOL package112. 
 
2.6. Energetic profile 
The MM-PBSA (Molecular Mechanics Poisson Boltzmann Surface Area) script
113
 integrated 
into the AMBER9 package114 was used to calculate the binding free energy difference 
upon alanine mutation.  The alanine mutations were performed on the interface residues 
that were previously selected in the structural analysis with the exception of alanine, 
glycine or proline residues. These were not mutated since have usually a primary role in 
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the protein stability and the mutation could lead to protein degradation. Due to the 
limitations of the method, residues that would only interact via backbone couldn’t be 
analyzed with computational ASM. This method combines a continuum approach to 
model solvent interactions with a MM-based approach to atomistically model protein-
protein interactions. It provides speed and accuracy and has been quite used in the last 
years113, 115-128. The MM-PBSA approach first developed by Massova et al.113 was 
improved by Moreira et al.119 and can now be applied with an accuracy of 1 kcal/mol. The 
mutant complexes are generated by a single truncation of the mutated side chain, 
replacing Cγ with a hydrogen atom and setting the Cβ-H direction to that of the former 
Cβ-Cγ. For the binding energy calculations, a total of 25 snapshots of the complexes were 
extracted in the last 1 ns of the run. The ∆∆G is defined as the difference between the 
mutant and wild type complexes defined as: 
∆∆G  ∆G	 	∆G	1					23	
Typical contributions to the free energy include the internal energy (bond, dihedral, and 
angle), the electrostatic and the van der Waals interactions, the free energy of polar 
solvation, the free energy of nonpolar solvation, and the entropic contribution: 
G11 	E1¡ 7 E11¡¢ 7	E£¤ 7	G¡	¢£	 7	G¡	¢£
 	TS							24	
For the calculations of relative free energies between closely related complexes, it is 
assumed that the total entropic term in equation 2 is negligible as the partial 
contributions essentially cancel each other.124 The first three terms of equation 2 
were calculated with no cutoff. The Gpolar solvation was calculated by solving the Poisson-
Boltzmann equation with the software DELPHI129, 130. In this continuum method, the 
protein is modeled as a dielectric continuum of low polarizability embedded in a 
dielectric medium of high polarizability. We used a set of values for the DELPHI 
parameters that proven in a previous study to constitute a good compromise between 
accuracy and computing speed131. We used a value of 2.5 grids/Å for scale (the 
reciprocal of the grid spacing); a value of 0.001 kT/c for the convergence criterion; a 
90% for the fill of the grid box; and the coulombic method to set the potentials at the 
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boundaries of the finite-difference grid. The dielectric boundary was taken as the 
molecular surface defined by a 1.4 Å probe sphere and by spheres centered  on each 
atom with radii taken from the Parse132 vdW radii parameter set. The key aspect of 
the new improved approach is the use of a three dielectric constant set of values (ε=2 
for nonpolar residues, ε=3 for polar residues and ε=4 for charged residues plus 
histidine) to mimic the expected rearrangement upon alanine mutation (the method 
is described at 117, 119). It is important to highlight that we used only one trajectory for 
the computational energy analysis as it has been proven to give the best results119 
Side-chain reorientation was implicitly included in the formalism by raising the 
internal dielectric constant. The nonpolar contribution to the solvation free energy 
due to van der Waals interactions between the solute and the solvent was modeled as 
a term dependent of the solvent accessible surface area (SASA) of the molecule. It 
was estimated by 0.00542×SASA+0.92 using the molsurf program developed by Mike 
Connolly133. 
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3. Experimental Methods 
3.1. Molecular Genetic Techniques  
3.1.1. Competent Cell preparation 
a) Inoculate 50ml of OXOID medium with the E. coli strains E. coli DH5α and E. coli 
BL21, at 37°C. 
b) Inoculate 200ml of OXOID medium previously warmed at 37°C with 2ml of the 
previous culture and incubate at 37°C with stirring, until OD600 between 0.2 and 
0.375 is achieved. 
c) Place the culture in pre-cooled tubes and put them in ice for 15min. 
d) Centrifuge at 3000rpm for 15 minutes, at 4°C. 
e) Elutriate the supernatant and ressuspend, slowly, the sediment in 20ml of pre-
cooled 100mM CaCl2 solution. Incubate in ice for 20 minutes 
f) Centrifuge the cells in 0.5ml of 100mM CaCl2 solution, at 4°C. Incubate in ice between 
for 24 hours for maximum transformation efficiency (efficiency increases in time, 
up to 24h. After that period cells rapidly lose their competency). 
g) Add glycerol to the competent cells for a final concentration of 10% V/V and 
freeze the mixture at -70°C. 
 
Transformation was performed with the synthetized plasmids, with the sequences of 
interest inserted.  
The sequences inserted had the following structure: 
CCATGG-GC-TEM sequence without termination codon TAA-CACCATCACCATCAC-TAA-
CTCGAG 
Sequences in orange are sequences detected by restriction enzymes (restriction sites), 
sequence in blue was used to keep the sequence for TEM enzymes in the correct open 
reading frame, the termination code was rejected from the sequence because we want a 
Tag on the produce protein (His Tag was chosen – sequence in red) and TAA is the 
termination code. 
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3.1.2. Bacterial Transformation 
a) Unfreeze the competent bacteria in ice. 
b) Put 5µl of plasmidic DNA solution in microtubules and keep them in ice. 
c) Add 50µl of competent cells to each microtubule and use circular movements to 
mix them, with the tip of the pipette. 
d) Incubate in ice for 20 minutes. 
e) Put each microtubule in a bath at 37°C for 2 minutes – Thermic shock. 
f) Place the microtubules in ice for 2 minutes. 
g) Add 200µl of OXOID medium and incubate at 37°C with stir. 
h) Plate 10µl of cells for each Petri plate. 
i) Incubate the plates at 37°C over-night. 
 
3.2. Microbiology Technics 
3.2.1. Bacterial strains  
Bacterial strains used in the present study included E. coli strain ATCC 25922 from 
American Tissue and Cell Culture, for antimicrobial susceptibility testing. Other strains of 
E. coli included E. coli DH5α and E. coli BL21 for cloning procedures.  
 
3.2.2.  Culture media and buffers 
3.2.2.1. General transport and store media 
 Tryptic soy media 3.2.2.1.1.
TSA and TSB are a basic media used for culturing many kinds of microorganisms. Tryptic 
soy agar is mainly used as an initial growth medium observation of colony morphology, 
developing a pure culture, achievement of sufficient growth for further biochemical 
testing, and culture storage (Finegold et al., 1978; MacFaddin, 1985).  
A dehydrate commercial form of these media was used (CULTIMED) and the hydratation 
was made according manufacturer indications. The medium was confirmed for pH 7.3 
prior to autoclaving for 15 min at 121 °C. Before plating the medium was cooled until 55 
ºC. 
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 SOC (Super Optimal Culture) medium 3.2.2.1.2.
SOC medium was used in cloning procedures since it is referred to as a good medium for 
E. coli growing (Hanahan, 1983). This medium is composed by tryptone 20g, yeast extract 
5 g and NaCl 0.5g. Then, when all solutes were dissolved in 950 mL of water, it was added 
10 mL of 250 mM (1.86g/100 mL) of KCl and pH was adjusted to 7.0 with 0.5 M NaOH 
(~0.2 mL). The volume was adjusted up to 1 L. The medium was sterilized by autoclave at 
121 ºC for 15 minutes. When the solution was cooled down to room temperature (RT) 20 
mL of 1 M sterile glucose (18 g /100 mL and sterilize by passing through a 0.22 µL filter) 
were added. Just before use 5 mL of autoclaved 2M MgCl2 (19g of MgCl2 in 100 mL) were 
added (Sambrook & Russel, 2001). 
 
 Antibiotic susceptibility medium: Mueller-Hinton  3.2.2.1.3.
Mueller-Hinton agar is recommended for the disk diffusion method of antibiotic 
susceptibility testing by FDA from WHO and CLSI for testing most commonly encountered 
aerobic and facultative anaerobic bacteria in food and clinical material. The medium 
shows good batch-to-batch reproducibility. It yields satisfactory growth of most non-
fastidious pathogens. Beef infusion and casein provide nitrogenous compounds, vitamins, 
carbon, sulphur and amino acids in Mueller-Hinton media. Starch is added to absorb any 
toxic metabolites produced. 
Mueller-Hinton medium was purchased as a dehydrate form (OXOID) and the hydratation 
was made according manufacturer suggestions. The medium was confirmed for pH 7.3 
prior to autoclaving for 15 min at 121 °C. Before plating the medium was cooled until 55 
ºC. 
3.2.3. Antibiotics’ stock solutions 
3.2.3.1. Ampicillin 
Ampicillin (APPLICHEM) stock solution was prepared to a final activity of 50 mg/mL on 
distilled water being further sterilized and aliquots were passed through a prerinsed 0.22 
µm filter. Ampicillin aliquots were stored at -20 ºC. 
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3.2.4. Susceptibility methods  
Antimicrobial susceptibility testing was performed by disc diffusion (Kirby-Bauer) method 
according to the CLSI guidelines, using as control E. coli strain ATCC 25922. 
 
3.2.4.1. Kirby-Bauer Disc diffusion method 
When a filter paper disc impregnated with a chemical is placed on agar the chemical will 
diffuse from the disc into the agar. This diffusion will dispense the chemical in the agar 
only around the disc. The solubility of the chemical and its molecular size will determine 
the size of the area of chemical infiltration around the disc. If an organism is placed on the 
agar it will not grow in the area around the disc if it is susceptible to the chemical. This 
area of no growth around the disc is known as a “zone of inhibition” (Joyce & Woods, 
2004).  
Many conditions can affect a disc diffusion susceptibility test. When performing these 
tests several parameters were held constant so only the size of the zone of inhibition is 
variable. Conditions that must be constant from test to test include the agar used, the 
amount of organism used, the concentration of chemical used, and incubation conditions 
such as time, temperature, and atmosphere (Pfaller & Jones 2006). The amount of 
organism used is standardized using a turbidity standard. This may be a visual 
approximation using a McFarland standard 0.5 or turbidity may be determined by using a 
spectrophotometer (optical density of 1.0 at 600 nm). For antibiotic susceptibility testing 
the antibiotic concentrations are predetermined and commercially available. Each test 
method has a prescribed media to be used and incubation at 35-37 ºC in ambient air for 
18-24 hours (CLSI, 2003; CLSI, 2005). 
The agar used was Mueller-Hinton (OXOID) agar. This method is well documented and 
standard zones of inhibition have been determined for susceptible and resistant values. 
Quality control strains E. coli ATCC 25922 were also used according CLSI guidelines. Discs 
purchased from OXOID that were used in the present study included APSM 30/10µg,  
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CXM 30µg, FOX 30µg, CTX 30µg, CAZ 30µg, IMI 10µg, GEN 30µg, CIP 5µg, SXT 25µg, 
CRO.30 µg, TZP 110 µg, AZM 15 µg, FD 10 µg, VA 30 µg, E 15 µg, TOB 10 µg, DA 2 µg, OX 1 
µg, P 10 units, NOR 10 µg, LEV 5 µg, MXF 5 µg, N 300 µg, CLR 15 µg, CEC 30 µg, TEC 30 µg, 
MUP 5 µg, RD 5 µg and LZD 30 µg. 
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4. Theoretical results and discussion  
4.1. Docking protein-ligand 
4.1.1. Enzymatic ensemble 
To inquire the stability of the docking complexes through the MD simulation, the RMSD 
was calculated for the protein backbone and for the ligand (C, N, O and S atoms were all 
selected). The RMSD presented in Figure 12, shows that the MD simulations are very 
stable (RMSD lower than 2Å). It can be seen that the variance along the MD simulation 
never surpasses 0.6Å. Therefore, the proteins backbone is very stable.  
 
A 
B 
C 
Figure 12: Graphical representation of the RMSDs of the backbone for TEM-180 (A), TEM-201 (B) and TEM-1 (C). 
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Although RMSD analysis of the three simulations have shown good backbone stability 
through the 16ns, after visual inspection it becomes clear the importance of the 
enzymatic ensemble. Visible changes in the secondary structures of β3 and β4 – H11 did 
indeed occur during the MD simulation. The selected microstates for TEM-1 (Figure 13-C) 
show less noticeable structural differences than TEM-180 (Figure 13-A) and TEM-201 
(Figure 13-B), which is consistent with the RMSD data. In the last 6ns, the backbone is 
more stable for TEM-1 than for TEM-180, and the latter more stable than the TEM-201 
backbone. For TEM-180 the most relevant differences occur in the lower portion of β4 
strand (near Arg244) and H11 (near Arg275). In TEM-201 there are more noticeable 
differences in the β4 strand and H11 than in TEM-180. This appears to lead to the 
formation of a helical structure between these two domains, most likely due to a greater 
distance between them. Also, the Ω-loop shows greater variance in TEM-201 than in the 
TEM-1 and TEM-180. It becomes clear that it is important to take into account the 
structural variance of the proteins in time. 
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A  
B  
C  
Figure 13: Representation of the six microstates (ensemble) selected from the MD simulation of TEM-180 (A), TEM-
201 (B) and TEM-1 (C) 
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4.1.2. Organic compounds docking 
To better analyze the Docking results it was beneficial to have an X-ray structure of a TEM 
enzyme in complex with some of the chosen antibiotics. However, no structure was found 
with TEM enzymes and these antibiotics, previously to acylation. Two complexes were 
found with TEM variants and two different antibiotics: these were of intermediates of the 
acylation reaction complexes. Given these shortcomings, the structural poses that 
resulted from the docking procedures were analyzed with several parameters as 
described in 2.3 Molecular Docking. The TEM variants under study formed complexes 
with all Penicillins (ampicillin, amoxicillin and methicillin), carbapenemes (Imipenem and 
meropenem) and Cefpirome. TEM-1 only formed complexes with ampicillin, amoxicillin 
and clavulanic acid.  
Complexes shown in Figure 14, present ampicillin deep into the catalytic pocket with the 
same general orientation. The carbonyl group of the β-lactam ring faces Ser70 and the 
entire ligand is positioned between the back wall of the catalytic pocket and Tyr105. This 
ligand position would be the perfect one for this type of complex but it might not be an 
eliminating factor due to the rotating capacity of the ligand molecules within the catalytic 
pocket.  
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A  
B  
C  
Figure 14: Structural representation of the complex TEM-180/Ampicillin (A), TEM-201/Ampicillin (B) and TEM-
1/Ampicillin. Ampicillin is in white stick representation and the interfacial residues are in orange stick representation. 
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The three complexes obtained with Amoxicillin are represented in Figure 15. They show 
the ligand in the same position in the catalytic pocket. The geometry of the ligand in TEM-
1 complex (Figure 15-C) is not the most favorable. However, as it is still protected by 
Tyr105, it was selected. The geometry shown for TEM-1 complex might be one of the 
facts that justify TEM-1 having less activity against Amoxicillin than against Ampicillin. 
 
A  
B  
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C  
Figure 15: Structural representation of the complex TEM-180/Amoxicillin (A), TEM-201/Amoxicillin (B) and TEM-
1/Amoxicillin. Amoxicillin is in white stick representation and the interfacial residues are in orange stick 
representation. 
 
The complexes with Clavulanic acid (Figure 16) present very similar position of the ligand, 
within the catalytic pocket, with the carboxyl group of the β-lactam ring facing Ser70. It is 
noticeable that all three complexes have the ligand molecule close to the β3 strand. 
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Figure 16: Structural representation of the complex TEM-180/Clavulanic acid (A), TEM-201/Clavulanic acid (B) and 
TEM-1/Clavulanic acid. Clavulanic acid is in white stick representation and the interfacial residues are in orange stick 
representation. 
The complexes obtained from Molecular Docking with Cefpirome present similar ligand 
location and overall geometry for TEM-180 (Figure 17-A) and TEM-201 (Figure 17-B). In 
both cases, the carbonyl group of the β-lactam ring faces Ser70 and the entire molecule is 
located near β3 strand with the ring that contains a sulfur atom interacting with the β3-
β4 loop. The other aromatic substituent follows β3 strand and faces to the exterior of the 
pocket. 
A  
B  
Figure 17: Structural representation of the complex TEM-180/Cefpirome (A), TEM-201/Cefpirome (B). Cefpirome is in 
white stick representation and the interfacial residues are in orange stick representation. 
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The complexes with Imipenem show similar ligand location but the complex with TEM-
180 (Figure 18-A) has the ligand closer to the catalytic serine (Ser70) than the complex 
with TEM-201(Figure 18-B). The main difference observed between the two is on the 
orientation of the side chain of the ligand. In Figure 18-A Imipenem side chain is located 
closer to Tyr105, possibly interacting with it, while in Figure 18-B the same side chain is 
closer to β3 strand and H11. 
 
A  
B  
Figure 18: Structural representation of the complex TEM-180/Imipenem (A), TEM-201/Imipenem (B). Imipenem is in 
white stick representation and the interfacial residues are in orange stick representation. 
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As shown in Figure 19, both complexes have the ligand in the same position and relative 
orientation within the catalytic pocket. The carboxyl group is facing Ser70 and 
Meropenem is placed along the β3 strand in both cases with a minor difference in the 
position of the side chain ring. In complex with TEM-180 (Figure 19-A) this ring has its 
substituent facing the opposite side of the pocket to β3 and in complex with TEM-201 
(Figure 19-B), the same substituent it is closer to the β3-β4 loop. 
 
A  
B  
Figure 19: Structural representation of the complex TEM-180/Meropenem (A), TEM-201/Meropenem (B). 
Meropenem is in white stick representation and the interfacial residues are in orange stick representation. 
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Although Methicillin has been described as resistant to the TEM family of β-lactamases 
because of its bulky ortho-dimethoxyphenyl group, directly attached to the side-chain 
carbonyl group of the penicillin nucleus, it was included in the study and so Molecular 
Docking was performed and good complexes were obtained for both TEM variants. 
As seen in Figure 20 the large cavity of these TEM variants can receive the ligand 
molecule in the best orientation for the acylation reaction (carboxyl group of the β-lactam 
ring facing catalytic Ser70) and protecting the ortho-dimethoxyphenyl group from 
solvent. It might be the reason for its resistance to this type of β-lactamases. It is 
noticeable that for TEM-201 (Figure 20-B) the referred group appears to be more 
protected from the solvent because it is closer to the β3-H11 interface instead of being 
position in the center of the pocket like in TEM-180 (Figure 20-A). 
 
A  
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B  
Figure 20:  Structural representation of the complex TEM-180/Methicillin (A), TEM-201/Methicillin (B). Methicillin is 
in white stick representation and the interfacial residues are in orange stick representation. 
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4.2. Molecular Dynamics- Structural and Energetic Analysis 
4.2.1. MD stability 
To investigate the stability of the complexes visual we have visually inspected the MD 
simulation to better understand the variances observed in RMSD graphics (Figure 21-A to 
C; Figure 34-49) 
The RMSD for complexes protein/Ampicillin shows more variation for TEM-180 (Figure 
21-A) and for TEM-1 (Figure 21-C) than for the complex with TEM-201 (Figure 21-B). This 
can be explained due to the inferior stability of the aromatic ring in the side chain, which 
leads to more movement of this structure. In TEM-201 the aromatic ring interacts with β3 
strand leading to higher stability.  
A  
B  
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Figure 21: Graphic representation of the RMSD of the complexes TEM-180/Ampicillin (A), TEM-201/Ampicillin (B) and 
TEM-1/Ampicillin (C). In blue is the RMSD for the protein backbone and in green the RMSD of Ampicillin 
The complexes of the proteins TEM-180, TEM-201 and TEM-1 with amoxicillin (Figure 34, 
Figure 35, Figure 36 respectively – S.I.) present very good stability for both for the ligand 
and the backbone. The difference between these RMSDs and the RMSDs of complexes 
with Ampicillin might be the result of the extra hydroxyl group in the aromatic ring of the 
ligand side chain, which might interact with nearby residues leading to higher stability 
during the MD simulation. 
The MD simulations of complexes with Clavulanic acid present very low RMSD in all three 
complexes as does not possesses a bulky and long side chains. Therefore, the only 
deviations that can be observed are the result of the torsion of the two rings that are the 
core structure of it. The differences observed in TEM-201/Clavulanic acid complex (Figure 
38 – S.I.) are not significant as no relevant differences were found. 
The complexes with Cefpirome have shown two different behaviors during the MD 
simulation. The complex with TEM-180 (Figure 40) was very stable during the MD for both 
protein and ligand. In this system Cefpirome was kept very stable with the bulky 
substituents being stabilized efficiently by nearby residues. The complex with TEM-201 
(Figure 41) had a major repositioning of the aromatic substituent linked to the core of the 
antibiotic. After this, the ligand shows great stability. 
The complexes of the two TEM variants with Imipenem (Figure 42 for complex with TEM-
180 and Figure 43 for complex with TEM-201 – S.I.) apparently show a considerable RMSD 
fluctuation. However, in fact, for both cases this is the result of the movement of the long 
side chain within the catalytic pocket and does not have a major effect on the ligand 
stability. The core of the antibiotic is very stable. 
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The complexes of the TEM variants with Meropenem show the same RMSD behavior as 
with Imipenem and fluctuation (Figure 44 and Figure 45 – S.I.). Although similar, the 
complexes with Meropenem are more stable than the ones with Imipenem. It is the result 
of interactions with β3 strand, which are present on this ligand and not with Imipenem 
(new ring at the end of the side chain that contains a nitrogen atom). 
The complexes with Methicillin had a different behavior between them. The complex 
TEM-180/Methicillin (Figure 46) presented a more erratic behavior during the MD 
simulation, which translates into significant RMSD variations. This ligand within this TEM 
variant has shown the capability to rotate inside the catalytic pocket after the 6th ns. This 
rotation is happens with periodicity which causes the variation observed in Figure 46. It 
always takes similar time interval to make 180° rotation, inverting the ligand within the 
pocket and then making it return to the original position. 
The complex TEM-201/Methicillin (Figure 47) suffers a slight rotation in the beginning of 
the simulation but after this it remains very stable during the MD simulation. These 
differences might be the result of a larger β3 and β4-H11 interface, which increases the 
capability of TEM-201 to interact with the bulky side chain, stabilizing it and also 
protecting it from solvent. 
All the performed MD simulations have shown great stability for the backbone of the 
proteins, which is in accordance with the bibliography that states that these type of β-
lactamases have an extremely stable backbone that gives them the high tolerance that to 
mutations.   
 
4.3. Structural and Energetic profiling 
The TEM variants presented in this study have shown to form complexes with all the 
various ligands referred in the Organics Compound Docking part. However, given the 
complexity of the reactions involved in the hydrolysis and inhibition of this class of 
enzymes and since the stability of a ligand does not necessarily translate into 
degradation/enzyme inhibition, it is not adequate to rely only on the absolute free 
binding energy (ΔGbinding) to distinguish the capacity of the organic compounds. It is well 
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known that the reaction of acylation of the β-lactam ring does not involve only the 
catalytic residues but also a complex network of H-bonds that lead to an abstraction of a 
hydrogen of the Serine residue. It has been previously proposed that Glu166 might be the 
initial reaction base residue (after the abstraction of a hydrogen by a water molecule), 
abstracting an hydrogen from Lys73, which would then abstract the hydrogen from the 
hydroxyl group of the Ser70. Lys73 has been described not only as a possible initial base 
but also as a stabilizer of nearby residues (Ser130 and Ser70) and as having a possible 
stabilizing effect as far as ligand position goes. Other theories have arisen with the study 
of various TEM variants and it has been proposed that Lys73 might be, in certain cases, 
the initial base residue. Although, it was shown the importance of these residues, it is not 
clear the definite purpose of some of them and how they might influence the reactions 
on the catalytic site. It becomes necessary to take into account several aspects of the 
enzyme itself and the complexes formed for a correct comprehension of the crucial 
system. 
To analyze the structure of the complexes, more specifically the interfacial residues, B-
factor values (Table 8) were calculated (B-factor describes the displacement of the atomic 
positions from an average value). The number of water molecules (Table 9) was also 
calculated to investigate the presence of water molecules near the catalytic residues, as 
well as, others that might contribute to the stability of the complex. It also allowed a 
better comprehension of the capability of the enzymes to hydrolyze the antibiotics. To 
investigate if the H-bond network between the catalytic residues is maintained through 
the simulation, relevant distances were also calculated (Table 10). 
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Table 8: Calculated B-factor of interfacial residues both for backbone (BB) and all-atom (AA) for the analyzed complexes 
 
 
TEM-180 TEM-201 TEM-1 TEM-180 TEM-201 TEM-1 TEM-180 TEM-201 TEM-1 TEM-180 TEM-201 TEM-1 TEM-180 TEM-201 TEM-1 TEM-180 TEM-201 TEM-1
Met 69 5,14 8,87 8,50 6,73 14,50 11,16 5,05 3,84 8,72 8,56 5,48 13,72 3,77 4,05 6,19 5,13 5,09 11,00
Ser 70 5,41 7,71 10,34 6,80 9,68 19,28 5,09 5,60 9,57 12,95 8,85 25,17 3,79 5,13 6,25 4,83 12,64 16,97
Lys 73 3,73 3,86 6,01 5,63 5,48 8,65 3,18 3,15 4,83 4,13 4,55 6,48 3,23 3,30 3,93 3,92 4,72 5,17
Tyr 105 9,30 17,25 19,98 23,37 86,49 62,95 9,26 9,87 11,15 13,82 41,16 34,95 10,75 13,30 12,82 47,13 15,28 37,42
Ser 130 6,03 11,15 8,16 14,39 22,18 12,40 5,02 7,17 7,34 11,32 8,86 11,68 4,48 7,90 9,80 5,20 16,47 13,75
Asn 132 4,03 6,14 8,39 9,51 12,22 13,44 2,86 4,74 5,02 5,70 13,62 36,22 3,50 6,70 5,09 6,48 8,27 7,40
Glu 166 5,18 9,68 15,98 11,01 13,32 20,37 7,43 5,87 9,64 12,18 11,55 13,38 4,36 4,70 7,01 5,41 5,92 11,99
Asn 170 6,75 12,47 9,06 11,91 25,74 23,30 7,24 6,19 10,69 20,12 7,27 32,14 4,64 6,00 13,69 5,21 6,30 21,09
Val 216 8,58 11,80 10,39 20,84 9,43 15,10 6,23 13,24 10,42 8,34 27,27 15,26 12,45 21,07 13,97 26,18 34,38 59,64
Lys 234 3,42 4,43 4,82 7,80 11,00 7,59 2,95 4,04 4,42 4,27 5,44 7,57 5,37 4,31 4,67 5,92 7,70 8,39
Ser 235 4,31 4,89 6,61 5,52 13,28 8,38 5,22 3,78 5,73 10,45 13,95 7,47 9,87 4,53 6,70 13,63 16,07 8,25
Glu 239 6,85 10,07 7,02 21,07 30,69 27,15 6,86 6,06 16,14 44,68 37,28 38,54 9,91 7,22 8,41 39,46 29,29 22,33
Arg 244 4,66 5,50 4,77 17,57 27,23 19,74 4,80 3,61 4,64 31,21 21,10 19,87 5,10 3,63 5,08 41,48 15,72 22,21
Arg 275 11,15 11,57 9,93 31,57 18,43 18,65 12,21 9,43 8,63 21,10 24,08 52,42 31,84 10,36 9,07 49,02 22,65 15,39
Clavulanic acid
BB AA
Amoxicillin
B-Factor
BB AA
Ampicillin
Residue BB AA
TEM-180 TEM-201 TEM-180 TEM-201 TEM-180 TEM-201 TEM-180 TEM-201 TEM-180 TEM-201 TEM-180 TEM-201 TEM-180 TEM-201 TEM-180 TEM-201
Met 69 6,78 4,95 11,64 8,42 6,61 6,99 14,87 8,14 6,27 4,90 7,62 6,28 9,68 5,10 28,50 5,97
Ser 70 5,10 4,74 9,32 14,03 8,73 7,13 28,52 14,58 7,79 4,63 14,22 7,27 12,43 5,63 45,53 6,92
Lys 73 3,90 3,46 6,60 4,10 4,28 3,65 7,14 5,77 3,31 3,59 4,70 5,76 3,76 4,32 4,07 6,96
Tyr 105 13,26 9,09 32,35 40,68 7,58 10,08 13,29 88,97 8,60 11,82 7,14 101,74 13,00 14,01 123,12 41,18
Ser 130 8,12 5,39 17,94 10,61 6,18 7,57 11,08 12,77 4,94 11,89 8,92 16,07 7,32 7,62 23,46 10,67
Asn 132 7,61 3,83 19,62 13,57 3,43 5,56 4,71 6,65 3,65 5,66 5,82 11,07 4,68 5,01 13,31 11,69
Glu 166 13,67 5,07 17,69 14,44 5,08 5,10 5,77 6,14 5,84 6,60 15,46 13,57 9,40 7,52 24,41 12,76
Asn 170 8,04 11,01 10,23 14,86 10,14 7,86 26,63 9,76 4,61 7,15 6,06 11,76 18,36 8,07 49,87 9,63
Val 216 38,58 10,77 36,46 15,74 9,40 48,97 19,86 67,35 11,47 10,71 22,47 13,32 13,32 19,68 20,89 24,59
Lys 234 4,98 5,24 9,92 7,35 5,52 5,76 6,01 15,88 3,53 3,50 5,51 13,49 5,23 8,64 6,09 14,36
Ser 235 6,60 9,74 8,84 16,02 12,08 15,07 18,91 20,58 3,93 4,36 6,31 6,10 12,76 7,31 20,83 15,86
Glu 239 7,68 14,34 34,04 50,29 7,57 15,41 26,73 60,50 5,27 8,14 25,03 37,82 7,30 9,90 47,30 33,93
Arg 244 5,34 8,68 43,16 45,07 5,19 8,50 26,48 16,71 4,07 5,01 22,65 20,44 6,11 5,73 6,86 25,89
Arg 275 19,30 20,80 33,15 52,12 16,04 11,68 44,69 13,16 11,56 39,83 28,54 218,54 14,81 18,99 28,09 35,70
B-Factor
Imipenem
BB AA
Meropenem
BB AA
Methicillin
Residue BB AA BB AA
Cefpirome
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Table 9: Number of water molecules in the micro-environment of the interfacial residues, for the analyzed complexes, at 4Å. Highlighted in red is the number of water molecules 
around the HS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TEM-180 TEM-201 TEM-1 TEM-180 TEM-201 TEM-1 TEM-180 TEM-201 TEM-1 TEM-180 TEM-201 TEM-180 TEM-201 TEM-180 TEM-201 TEM-180 TEM-201
Met 69 0,00 0,01 0,00 0,00 0,00 0,01 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,01
Ser 70 0,77 0,26 3,23 0,55 0,50 1,71 0,09 1,59 1,84 0,25 1,35 0,84 0,75 1,58 3,39 4,76 3,56
Lys 73 0,60 2,29 1,61 0,86 0,48 1,62 0,00 1,03 0,87 3,04 0,00 0,66 0,72 0,60 1,46 1,50 1,99
Tyr 105 3,41 3,61 3,10 2,84 1,46 1,84 2,14 1,01 1,90 2,42 2,30 1,52 1,63 1,57 1,77 2,07 2,71
Ser 130 1,99 2,29 2,04 0,00 0,90 2,06 1,62 1,76 3,08 1,42 1,94 1,23 2,38 1,27 5,04 2,31 4,38
Asn 132 0,26 2,80 3,39 1,46 0,34 2,84 1,80 2,74 1,77 3,05 1,80 1,48 0,23 0,85 2,58 3,07 2,72
Glu 166 0,42 2,62 1,53 1,44 0,52 1,84 0,19 1,03 0,05 3,28 0,83 0,57 0,00 0,55 1,49 2,25 1,08
Asn 170 0,01 4,61 3,28 1,44 0,79 2,22 0,04 1,06 1,70 1,79 1,44 0,16 0,27 0,57 1,27 2,23 1,51
Val 216 1,64 3,59 3,72 0,00 2,17 2,48 1,04 2,35 3,57 3,41 3,28 0,37 2,10 2,37 3,82 1,42 4,38
Lys 234 0,27 2,07 1,10 0,00 0,47 1,35 0,00 1,70 1,50 0,57 1,13 0,00 1,87 1,04 3,69 0,09 2,56
Ser 235 0,00 0,85 0,00 0,53 0,03 0,00 1,32 0,00 0,00 1,14 2,17 1,23 1,68 0,89 2,57 1,22 2,63
Glu 239 6,22 6,27 6,40 6,06 5,98 6,24 5,96 5,82 5,43 5,67 5,87 1,77 4,95 3,68 5,81 5,38 4,13
Arg 244 2,98 4,32 2,77 3,57 3,92 3,15 5,24 2,97 2,77 3,42 5,44 4,28 3,38 2,28 5,84 4,83 4,33
Arg 275 4,45 1,43 4,21 3,62 4,19 2,57 5,12 4,32 4,09 5,79 3,97 2,40 2,75 3,50 3,93 4,57 4,09
Cefpirome Imipenem Meropenem Methicillin
Number of water molecules
Residues
Clavulanic acid Ampicillin Amoxicillin
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Table 10: Average distances (Å) between catalytic residues through the MD simulation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
χ ± σ
Ser70-Lys73 3,77 ± 0,22 4,74 ± 0,83 6,39 ± 0,51 4,46 ± 0,31 4,89 ± 1,40 3,40 ± 0,68 4,07 ± 0,30
Ser70-Ser130 4,57 ± 0,26 4,85 ± 0,43 4,77 ± 0,56 6,28 ± 1,03 4,35 ± 0,54 3,84 ± 0,38 7,39 ± 0,61
Lys73-Glu166 4,72 ± 0,17 2,84 ± 0,13 4,03 ± 0,30 2,76 ± 0,08 3,65 ± 0,24 3,64 ± 0,72 3,07 ± 0,23
χ ± σ
Ser70-Lys73 3,82 ± 0,26 3,46 ± 0,38 4,00 ± 0,24 7,01 ± 0,35 3,95 ± 0,42 3,57 ± 0,30 4,18 ± 0,25
Ser70-Ser130 4,58 ± 0,31 5,47 ± 0,72 7,44 ± 0,51 5,38 ± 0,87 6,48 ± 0,73 6,47 ± 0,40 7,48 ± 0,36
Lys73-Glu166 2,86 ± 0,15 2,73 ± 0,08 3,04 ± 0,21 2,83 ± 0,12 3,00 ± 0,21 2,80 ± 0,10 2,98 ± 0,28
Ampicillin Cefpirome Clavulanic acid
TEM-201
TEM-180
Imipenem Meropenem Methicillin
MethicillinMeropenemImipenemClavulanic acidCefpiromeAmpicillinAmoxicillin
Amoxicillin
5,48 ± 0,85 5,06 ± 0,99 4,92 ± 1,24
4,50 ± 0,61 5,28 ± 1,26 4,47 ± 0,51
3,42 ± 0,31 3,19 ± 0,30 3,32 ± 0,45
Ser70-Ser130
Lys73-Glu166
TEM-1 
χ ± σ
Ser70-Lys73
Amoxicillin Ampicillin Clavulanic acid
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Table 11: Relative free binding energy and S.D. for the interfacial residues of the various complexes using computational ASM 
 
  
ΔΔG S.D. ΔΔG S.D. ΔΔG S.D. ΔΔG S.D. ΔΔG S.D. ΔΔG S.D. ΔΔG S.D. ΔΔG S.D. ΔΔG S.D.
Met 69 0,15 ± 0,65 0,29  ± 0,60 0,18  ± 0,61 -0,12  ± 0,88 0,44  ± 0,70 -0,13  ± 1,07 0,68  ± 0,67 0,48  ± 1,04 -0,10  ± 0,81
Ser 70 1,03  ± 0,55 0,74  ± 0,59 0,25  ± 0,57 0,25  ± 0,70 0,27  ± 0,64 0,24  ± 0,87 0,96  ± 0,65 1,81  ± 0,84 0,24  ± 0,68
Lys 73 3,98  ± 0,63 0,72  ± 0,57 -0,02  ± 0,61 2,42  ± 0,70 2,19  ± 0,60 2,30  ± 0,85 3,23  ± 0,62 -3,36  ± 0,77 1,84  ± 0,69
Tyr 105 2,00  ± 0,56 -0,80  ± 0,60 0,25  ± 0,57 4,35  ± 0,77 3,59  ± 0,61 4,03  ± 0,88 3,72  ± 0,61 0,95  ± 0,79 2,95  ± 0,67
Ser 130 -0,15  ± 0,55 1,91  ± 0,52 0,17  ± 0,58 1,08  ± 0,73 1,27  ± 0,64 0,24  ± 0,87 0,04  ± 0,62 -2,12  ± 0,80 -0,05  ± 0,69
Asn 132 0,31  ± 0,55 0,23  ± 0,64 0,24  ± 0,57 3,75  ± 0,73 3,53  ± 0,60 0,02  ± 0,89 2,11  ± 0,64 -1,37  ± 0,80 1,22  ± 0,70
Glu 166 6,86  ± 0,62 0,23  ± 0,58 0,27  ± 0,62 1,24  ± 0,73 2,41  ± 0,61 0,62  ± 0,91 5,97  ± 0,70 8,49  ± 0,74 7,18  ± 0,56
Asn 170 1,51  ± 0,53 0,16  ± 0,62 0,27  ± 0,58 0,46  ± 0,74 5,41  ± 0,66 1,62  ± 0,79 3,62  ± 0,65 -8,34  ± 0,93 1,07  ± 0,67
Val 216 0,77  ± 0,62 1,11  ± 0,59 0,52  ± 0,61 2,76  ± 0,87 0,96  ± 0,70 -0,41  ± 1,00 0,00  ± 0,68 0,75  ± 1,02 -0,56  ± 0,85
Lys 234 0,67  ± 0,57 7,59  ± 0,64 -0,02  ± 0,61 1,41  ± 0,67 3,61  ± 0,67 1,30  ± 0,80 0,11  ± 0,66 -2,38  ± 0,81 -0,10  ± 0,66
Ser 235 -0,03  ± 0,58 0,00  ± 0,57 0,10  ± 0,59 -0,02  ± 0,70 -0,02  ± 0,61 -0,13  ± 0,89 -0,06  ± 0,61 -0,24  ± 0,84 -0,17  ± 0,70
Glu 239 0,02  ± 0,56 0,19  ± 0,60 0,16  ± 0,61 0,09  ± 0,67 -0,10  ± 0,59 1,20  ± 0,81 0,02  ± 0,66 7,86  ± 0,71 0,86  ± 0,62
Arg 244 0,25  ± 0,56 0,02  ± 0,60 0,11  ± 0,61 1,92  ± 0,67 0,08  ± 0,58 -0,09  ± 0,81 0,35  ± 0,67 -6,49  ± 0,72 -0,19  ± 0,67
Arg 275 -0,02  ± 0,55 -0,80  ± 0,59 0,13  ± 0,62 -0,15  ± 0,68 -0,01  ± 0,59 -0,06  ± 0,81 0,14  ± 0,64 -5,51  ± 0,71 -0,17  ± 0,65
TEM-1 TEM-1
ΔΔGbinding/[kcalmol- 1 ]
TEM-1
Clavulanic acid Ampicillin Amoxicillin
TEM-201 TEM-180 TEM-201 TEM-180 TEM-201Residue TEM-180
ΔΔG S.D. ΔΔG S.D. ΔΔG S.D. ΔΔG S.D. ΔΔG S.D. ΔΔG S.D. ΔΔG S.D. ΔΔG S.D.
Met 69 0,83  ± 1,08 0,37  ± 0,70 0,78  ± 0,74 0,16  ± 0,76 0,30  ± 0,94 0,71  ± 0,68 0,16  ± 0,61 0,03  ± 0,73
Ser 70 1,82  ± 0,98 1,57  ± 0,66 0,45  ± 0,66 0,00  ± 0,74 1,19  ± 0,89 1,82  ± 0,54 0,01  ± 0,52 -0,69  ± 0,67
Lys 73 4,59  ± 0,93 10,66  ± 0,73 1,36  ± 0,65 2,38  ± 0,79 6,80  ± 0,86 1,55  ± 0,47 1,61  ± 0,54 0,84  ± 0,60
Tyr 105 0,87  ± 0,97 2,58  ± 0,61 4,41  ± 0,67 4,06  ± 0,70 3,23  ± 0,78 3,31  ± 0,52 5,82  ± 0,56 2,38  ± 0,65
Ser 130 1,44  ± 0,94 0,32  ± 0,66 0,03  ± 0,67 0,15  ± 0,75 0,88  ± 0,84 0,09  ± 0,51 0,03  ± 0,52 0,16  ± 0,63
Asn 132 -0,12  ± 0,97 1,71  ± 0,62 1,07  ± 0,63 1,72  ± 0,71 1,54  ± 0,75 -0,90  ± 0,50 -0,05  ± 0,52 -0,33  ± 0,64
Glu 166 -1,40  ± 0,92 0,23  ± 0,66 5,84  ± 0,69 6,89  ± 0,68 4,81  ± 0,80 1,37  ± 0,46 -0,47  ± 0,56 0,25  ± 0,62
Asn 170 2,64  ± 0,95 2,56  ± 0,68 0,32  ± 0,64 1,65  ± 0,76 3,95  ± 0,83 2,61  ± 0,54 1,12  ± 0,51 1,83  ± 0,61
Val 216 2,94  ± 1,03 2,00  ± 0,67 0,18  ± 0,77 0,08  ± 0,78 0,62  ± 0,87 -0,10  ± 0,67 0,63  ± 0,51 -0,22  ± 0,70
Lys 234 5,12  ± 1,00 10,34  ± 0,66 0,21  ± 0,65 -0,13  ± 0,73 1,11  ± 0,77 1,95  ± 0,45 0,29  ± 0,53 0,19  ± 0,59
Ser 235 0,06  ± 0,99 -0,15  ± 0,65 0,03  ± 0,67 0,00  ± 0,74 -0,10  ± 0,83 0,09  ± 0,51 0,11  ± 0,55 0,19  ± 0,63
Glu 239 1,06  ± 0,93 0,12  ± 0,68 0,50  ± 0,62 -0,07  ± 0,73 1,41  ± 0,77 0,41  ± 0,46 0,75  ± 0,56 1,17  ± 0,58
Arg 244 -0,27  ± 0,96 0,35  ± 0,66 0,27  ± 0,65 -0,30  ± 0,76 -0,20  ± 0,79 0,33  ± 0,48 0,40  ± 0,55 0,00  ± 0,60
Arg 275 -0,82  ± 0,95 -0,14  ± 0,68 0,05  ± 0,65 0,30  ± 0,75 -0,04  ± 0,80 0,00  ± 0,47 -0,09  ± 0,54 0,11  ± 0,60
Methicillin
TEM-201 TEM-180 TEM-201 TEM-180 TEM-201
Cefpirome Imipenem Meropenem
TEM-180 TEM-201 TEM-180Residue
ΔΔGbinding/[kcalmol
-1]
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4.3.1. Analysis of complexes with Clavulanic acid 
The complexes formed with clavulanic acid have clearly shown different behavior 
between the three TEM variants under study.  
From the B-factor values (Table 8) measured for the three MD simulations, we can 
observe that Ser70, Lys73, Tyr105, Glu166, Asn170 are the residues that present the most 
distinct behavior between the TEM-1 and the mutant forms. With the exception of 
Asn170, these residues have a more stable backbone in TEM-180 and TEM-201 than in 
TEM-1. The side chain of Tyr105 in TEM-201 appears to be less stable than in the others 
(greater difference between the B-factor of all-atom and backbone). The water structure 
can be depicted in terms of RDF. We analyzed the RDF profiles and calculated the average 
number of waters within 4 Å (cutoff for meaningful interactions), which are listed in Table 
9. Ser70 and Glu166 show a clear different behavior when comparing the variants with 
TEM-1. The number of water molecules at a 4 Å cutoff of Ser70 is: 0.77 in TEM-180, 2.29 
in TEM-201 and 3.23 in TEM-1. At a 4 Å cutoff of Glu166 are: 0.42 in TEM-180, 2.62 in 
TEM-201 and 1.53 in TEM-1. As mentioned before, the existence of a conserved water is 
fundamental for the enzymatic process. In contrast with TEM-180 and TEM-1, TEM-201 
does not have a conserved water molecule near Glu166. This can lead to a decreased 
acylation of clavulanic acid, which translates into resistance to this β-lactamase inhibitor. 
The hydrogen network responsible for the acylation process has been altered for TEM-
201 with a significant increase in the distance between Ser70 and Ser130 (5.38 ± 0.87 Å 
for TEM-201 in opposition to 4.47 ± 0.51 Å for the TEM-1). Another important structural 
feature for the irreversible inhibition of the enzyme is altered. Ser70 and Lys73 are at 
greater distance in TEM-201 than in TEM-1 (7.01 ± 0.35Å for TEM-201 and 4.92 ± 1.24Å in 
TEM-1). The distance between the two serine residues that form an intermediary of the 
reaction (Ser70 and Ser130) is higher in TEM-180 than in TEM-1 (6.28 ± 1.03Å for TEM-
180 in opposition to 4.47 ± 0.51Å for TEM-1) avoiding in this manner the inhibition of 
Ser130 by covalent bonding (Table 10). TEM-180 presents a conserved water molecule 
near Glu146 but with a lower occupancy when compared with WT (51% against 86%), 
which might lead to decreased acylation and therefore, resistance to clavulanic acid. 
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The difference in the distance between Ser70 and Ser130 becomes clear when observing 
its variation during the MD simulation (Figure 22). 
A  
B  
C  
Figure 22: Graphical representation of the distance between Ser70 and Ser130 during the MD simulation in TEM-1 
(A), TEM-180 (B) and TEM-201 (C). 
 
The ASM analysis for TEM-180 has shown 3 HS: Lys73 (ΔΔGbinding=3.98 ± 0.63 kcalmol
-1), 
Tyr105 (ΔΔGbinding=2.00 ± 0.56 kcalmol
-1) and Glu166 (ΔΔGbinding=6.86 ± 0.62 kcalmol-1) 
and in TEM-201 1 HS – Lys234 (ΔΔGbinding=7.59 ± 0.64 kcalmol
-1). In TEM-180, Lys73 and 
Glu166 help stabilizing the bicyclic structure, mainly through hydrophobic interactions. 
Nevertheless, both can also bond by H-bonds with the oxygen groups from the ligand. 
Tyr105 has a major role by helping maintaining the acid inside the catalytic pocket (Figure 
23). 
Although, TEM-201 only presents 1HS (Lys234 with ΔΔGbinding=7.59 ± 0.64 kcalmol-1) that 
forms a H-bond with clavulanic acid (Figure 23), it shows other relevant interactions.  
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No relevant interactions for the binding free energy were found in TEM-1. For this 
enzyme the small size of the ligand might be the reason for these findings as the enzyme 
cannot bind to the acid for a long period of time. This fact does not mean that it would be 
less prone to inhibition because if the enzyme cans acylate the acid and form the 
intermediary, it will be irreversibly inhibited. This surpasses the fact that it isn’t as stable 
as in the ligands.   
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Figure 23: On the left panels are the complexes structures rendered in pymol112 (blue for TEM-180, red for TEM-201 
and green for TEM-1) and on the right panels are interaction maps made with ligplot108. The complexes correspond to 
the average structures from the MD simulations. 
 
4.3.2. Analysis of complexes with Amoxicillin 
The analysis of the interface with ASM (Table 11) shown that TEM-180 has more HS than 
the other two enzymes: Lys73 (ΔΔGbinding=3.23 ± 0.62 kcalmol
-1), Tyr105 (ΔΔGbinding=3.72 ± 
0.61 kcalmol-1), Asn132 (ΔΔGbinding=2.11 ± 0.64 kcalmol
-1), Glu166 (ΔΔGbinding=5.97 ± 0.0.7 
kcalmol-1) and Asn170 (ΔΔGbinding=3.62 ± 0.65 kcalmol
-1).It is important to notice that the 
backbone of Ser70 and Ala237 form H-bridges with amoxicillin (Figure 24). The HS in this 
protein help to stabilize the ligand through hydrophobic interactions. Asn residues and 
Tyr105 are capable of forming H-bridges with the nitrogen and oxygen atoms from the 
side chain helping with its stabilization (Figure 24). 
TEM-201 presented Glu166 (ΔΔGbinding=8.49 ± 0.74 kcalmol
-1) and Glu239 (ΔΔGbinding=7.86 
± 0.72 kcalmol-1) as HS because (Table 11) these residues stabilize the ligand with H-bonds 
and hydrophobic interactions. Glu166 has an important role on the orientation and 
stabilization of the bicyclic structure and Glu239 helps protecting the aromatic side chain 
from the solvent and it stabilizes the aromatic ring. Ala237 have shown through the entire 
MD simulation a major role in stabilizing both the bicyclic structure. Its lateral side chain 
interacts with the antibiotic through H-bonds (backbone atoms) (Figure 24). 
TEM-1 has Tyr105 (ΔΔGbinding=2.95 ± 0.67 kcalmol
-1) and Glu166 (ΔΔGbinding=7.18 ± 0.56 
kcalmol-1) as HS (Table 11). Tyr105 helps shielding the ligand from solvent and it stabilizes 
the lateral side chain of amoxicillin with its fenol structure. Glu166 helps stabilizing the 
bicyclic structure of the antibiotic with hydrophobic interactions. Although Asn132 does 
not have a ΔΔGbinding of 2Kcalmol
-1 or higher (Table 11), it still forms strong interactions 
with the polar atoms near the β-lactam ring (Figure 24). 
The only complex where it was possible to observe a conserved water molecule placed, 
most of the time near Glu166, was in complex TEM-201/amoxicillin. The fact that it is not 
observed in TEM-1 might justify why the catalytic activity against amoxicillin is inferior 
when compared to ampicillin (highly conserved water molecule near Glu166). Although in 
TEM-180/amoxicillin MD simulations, the presence of a water molecule near Glu166 is 
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inferior to 25% of the MD simulation time, it is still important to highlight that it has a 
highly conservative water molecule near Lys73. Lys73 has been previously described as a 
possible first base for the acylation process, and therefore can help to overcome the 
deficiency of a conserved water molecule near Glu166. It will lead to acylation of the 
antibiotic and biologic resistance to the antibiotic. 
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Figure 24: On the left panels are the complexes structures rendered in pymol112 (blue for TEM-180, red for TEM-201 
and green for TEM-1) and on the right panels are interaction maps made with ligplot108. The complexes correspond to 
the average structures from the MD 
 
4.3.3. Analysis of complexes with Ampicillin 
The complex TEM-180/ampicillin presented multiple HS (Table 11). Lys73 (ΔΔGbinding=2.42 
± 0.72 kcalmol-1), Tyr105 (ΔΔGbinding=4.35 ± 0.77 kcalmol
-1) and Val216 (ΔΔGbinding=2.76 ± 
0.87 kcalmol-1) are important for the binding of the antibiotic mainly because of the 
stabilization of the ligand via hydrophobic interactions while Asn132 (ΔΔGbinding=3.77 ± 
0.73 kcalmol-1) and Glu166 (ΔΔGbinding=1.24 ± 0.073 kcalmol
-1 – not a HS) stabilize 
ampicillin’s side chain with H-bonds. The interaction of this antibiotic with residues in the 
β3 chain is present through the entire simulation with particularly relevance of residues 
Gly236 and Ala237. Other interactions have been observed but with less significance. 
The complex formed with TEM-201 also has multiple HS (Table 11). Lys73 (ΔΔGbinding=2.19 
± 0.60 kcalmol-1) and Tyr105 (ΔΔGbinding=3.59 ± 0.61 kcalmol
-1) fulfill the same role as in 
the previously described complex. However, in this complex Glu166 (ΔΔGbinding=2.41 ± 
0.61 kcalmol-1) and Asn170 (ΔΔGbinding=5.41 ± 0.66 kcalmol
-1) also help to stabilizing the 
side chain of ampicillin with hydrophobic interactions as well but also with H-bonds 
(Figure 25). Asn 132 and Lys234 are also HS. Asn132 (ΔΔGbinding=3.53 ± 0.60 kcalmol
-1) 
forms an H-bond with the oxygen in the side chain and Lys234 (ΔΔGbinding=3.61 ± 0.67 
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kcalmol-1) with the oxygen atom in the substituents of the bicyclic structure. Ala237 has 
also shown great importance by stabilizing the side chain with an H-bridge between its 
nitrogen atom and the oxygen from the carbonyl group in the β-lactam ring and between 
its oxygen and the nitrogen in the antibiotic side chain. Several other interactions have 
been identified, and although alone might not represent a great effect of the ligand 
binding, together might have reasonable effect (Figure 25). 
TEM-1 presented only Lys73 (ΔΔGbinding=2.30 ± 0.85 kcalmol
-1) and Tyr105 (ΔΔGbinding=4.03 
± 0.88 kcalmol-1) as HS because of their interactions with the core of the antibiotic 
(hydrophobic interactions) and the aromatic ring (π-π interactions) respectively. 
Residues Asn170, Lys234 and Glu239 have shown inferior ΔΔGbinding (Table 11) than the 
previously discussed residues but they still show considerable importance for the 
interaction. Asn170 and Glu239 help stabilizing the ampicillin side chain, while Lys234 
interacts with the methyl groups of the bicyclic structure (Figure 25). Like before, Ala237 
have shown interaction with the antibiotic through the entire MD simulation. 
The activity of the variants might still be inferior against ampicillin due to the fact that the 
conserved water molecule near Glu166 suffers displacement and is present near this 
residue less than 25% of the time in the MD simulation. The H-bond network is 
maintained almost through all the MD simulation being both the backbone and side chain 
of the residues involved more stable in the variants that in TEM-1.  
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Figure 25: On the left panels are the complexes structures rendered in pymol112 (blue for TEM-180, red for TEM-201 
and green for TEM-1) and on the right panels are interaction maps made with ligplot108. The complexes correspond to 
the average structures from the MD 
 
4.3.4. Analysis of complexes with Cefpirome 
The ASM analysis of the interface TEM-180/Cefpirome showed Lys73 (ΔΔGbinding=4.59 ± 
0.93 kcalmol-1), Asn170 (ΔΔGbinding=2.64 ± 0.95 kcalmol
-1), Val216 (ΔΔGbinding=2.94 ± 1.03 
kcalmol-1) and Lys234 (ΔΔGbinding=5.12 ± 1.00 kcalmol
-1) as HS (Table 11). With the 
exception of Asn170, all of them help positioning and stabilizing the ligand with 
hydrophobic interaction (Asn170 forms H-bonds with the polar atoms from the ligand 
side chain - Figure 27). In this complex Lys234 does not interact with the ligand via H-
bonds because its side chain does not stay extended towards the catalytic pocket. 
Ala237 is of great importance in the ligand binding, stabilizing both β-lactam ring and side 
chain with H-bonds. 
The ASM analysis of the interface TEM-201/Cefpirome appointed Lys73 (ΔΔGbinding=10.66 
± 0.73 kcalmol-1), Tyr105 (ΔΔGbinding=2.58 ± 0.61 kcalmol
-1), Asn170 (ΔΔGbinding=2.56 ± 0.68 
kcalmol-1), Val216 (ΔΔGbinding=2.00 ± 0.67 kcalmol
-1) and Lys234 (ΔΔGbinding=10.34 ± 0.66 
kcalmol-1) as HS (Table 11). 
Lys73 and Lys234 interact with the oxygen atoms from the bicyclics substituents (H-
bonds) and Asn170 with the atoms at the end of the side chain (hydrophobic interactions 
and H-bonds). As in TEM-180, Val216 is a HS because in these complexes a high 
complementary can be achieved between the methyl groups from the Valine residue and 
the rings present in the substituent of the antibiotic (Figure 27). 
Tyr105 clearly shows that it interacts with the side chain of Cefpirome forming H-bonds. 
However, most likely its important role comes from its ability to have π-π interactions 
with the ring in the antibiotic side chain. 
Like in TEM-180, in the complex TEM-201/Cefpirome Ala237 stabilizes the β-lactam ring 
and the side chain with H-bonds. 
The average distance in the TEM-180/Cefpirome complex between Ser70 and Lys73 has 
increased. However, during a big part of the MD simulation it is still at an acceptable 
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distance, so that the H-bond network is still functional (Figure 26). In TEM-201/Cefpirome 
no major differences have been observed in the H-bond triad (Table 10). 
 
Figure 26: Graphical representation of the distance between Ser70-Oγand Lys73-Nζ during the simulation in TEM-180 
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Figure 27: On the left panels are the complexes structures rendered in pymol112 (blue for TEM-180 and red for TEM-
201) and on the right panels are interaction maps made with ligplot108. The complexes correspond to the average 
structures from the MD 
 
4.3.5. Analysis of complexes with Imipenem 
In TEM-180/Imipenem complex Tyr105 and Glu166 have been detected as HS with 
ΔΔGbinding=4.41 ± 0.67 kcalmol-1 and ΔΔGbinding=5.84 ± 0.69 kcalmol-1, respectively (Table 
11). Glu166 shows complementary between the carbon atoms in its side chain and the 
carbon atoms in the substituents near the β-lactam ring (Figure 28). It is possible that 
Glu166 interacts via H-bonds with the hydroxyl group of the same substituents. Tyr105 
helps stabilizing the long side chain of Imipenem and it can have some complementary 
with the ring next to the β-lactam ring (Figure 28). Ala237 and Ser70 have shown to 
interact with the ligand during most of the simulation through H-bonds. 
ASM of the interface TEM-201/Imipenem has shown that Lys73 (ΔΔGbinding=2.38 ± 0.79 
kcalmol-1), Tyr105 (ΔΔGbinding=4.06 ± 0.70 kcalmol-1) and Glu166 (ΔΔGbinding=6.89 ± 0.68 
kcalmol-1) as HS (Table 11). Tyr105 has high complementary between its aromatic ring 
and the bicyclic structure of the antibiotic (Figure 28). Glu166 and Lys73 help with the 
stabilization of the bicyclic structure of the antibiotic. Ala237 kept constant interactions 
with the ligand through all the MD simulation. 
In this complex, it is possible to observe that Arg244 interacts with the oxygen from one 
of the bicyclic structure substituents. It is notable that these ligands remain partially in 
contact with solvent causing destabilizing effects. It is the result of the Tyr105 not acting 
as a gate keeper fully locking the catalytic pocket, due to the size and freedom of 
movement of the long lateral side chain.   
The H-bond network is very stable for these complexes (Table 8) and the distances 
between Ser70, Lys73 and Glu166 remains stable and within distances acceptable for the 
H-bond network to be functional (Table 10). 
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A conserved water molecule was identified in TEM-180/Imipenem near Glu166 during 
most of the MD simulation, while for TEM-201/Imipenem no water molecule near this 
residue was identified longer than 25%. It is important to refer that despite this fact, it is 
possible that a catalytic triad is formed with other residue or even a water molecule. We 
have also identified a conserved water molecule within 5Å of Ser130, Lys73 and Ser70. 
Any of these residues is capable of replacing the role of Glu166 as first base in the 
acylation process when near a water molecule, leading to acylation of the antibiotic. 
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Figure 28: On the left panels are the complexes structures rendered in pymol112 (blue for TEM-180 and red for TEM-
201) and on the right panels are interaction maps made with ligplot108. The complexes correspond to the average 
structures from the MD simulation 
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4.3.6. Analysis of complexes with Meropenem 
In the complex with TEM-180, Ser70, Lys73, Asn132 and Glu166 interact with the acidic 
group via H-bridges and Ser70 also interacts with the oxygen from the carboxylic group of 
the β-lactam ring. Tyr105 is involved in hydrophobic interactions with the bulky side chain 
and Val216 interacts with the methyl group of the substituents. Asn170 acts as the back 
wall of the catalytic pocket and contributes for the ligand binding free energy with 
Meropenem mainly with hydrophobic contacts. 
Of all these residues Lys73 (ΔΔGbinding=6.80 ± 0.86 kcalmol
-1), Tyr105 (ΔΔGbinding=3.23 ± 
0.78 kcalmol-1), Glu166 (ΔΔGbinding=4.81 ± 0.80 kcalmol
-1) and Asn170 (ΔΔGbinding=3.95 ± 
0.83 kcalmol-1) have shown to have a greater effect on ligand binding energy than the rest 
of the residues in the interface (Table 11). 
The ASM analysis of the interface of the complex TEM-201/Meropenem (Table 11) has 
shown less HS than for TEM-180: Tyr105 with ΔΔGbinding=3.31 ± 0.52 kcalmol
-1 and Asn170 
with (ΔΔGbinding=2.61 ± 0.54 kcalmol
-1).However, it has other important interactions that 
help stabilizing the bicyclic structure of the antibiotic (Ser70 and Lys234). Tyr105 has 
complementary with one of the rings of the core of the antibiotic but it has even more 
complementary (hydrophobic contacts with one of the substituents). The trade-off of this 
interaction might be less protection of the antibiotic from the solvent, which can have a 
destabilizing effect of the complex. 
Asn170 stabilizes the ring present in the side chain and the oxygen from the carbonyl 
group of the tertiary amide. 
In both complexes Glu239 interacts with the tertiary amine group of Meropenem side 
chain, which helps keeping the side chain of the antibiotic close to β3 allowing Ala237 to 
interact with the acidic group of the antibiotic with H-bonds. Glu239 might also help 
protecting the tertiary amine group from solvent. 
In the complex TEM-201/Meropenem a highly conserved water molecule is presented 
near Glu166, which was not observer for the TEM-180/Meropenem complex. 
As with other complexes, described previously, a new water molecule was identified near 
Lys73 and Ser130 for more than 40% of the MD simulation time. It might give the enzyme 
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the capability to hydrolyze this antibiotic, and therefore leads to biological antibiotic 
resistance. 
 
 
 
 
Figure 29: On the left panels are the complexes structures rendered in pymol112 (blue for TEM-180 and red for TEM-
201) and on the right panels are interaction maps made with ligplot108. The complexes correspond to the average 
structures from the MD simulation 
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4.3.7. Analysis of complexes with Methicillin 
As described before, Methicillin inside the catalytic pocket of TEM-180 has an erratic 
behavior. So the structure represented above does not represent all the geometries 
observed for this ligand. The results from ASM (Table 11) indicate that there is only one 
HS (Tyr105 with ΔΔGbinding=5.82 ± 0.56 kcalmol
-1) and that is due to the fact that this 
residue shows complementary either with the aromatic ring in the side chain (π-π 
interactions) and with the core of the antibiotic. There have also been identified other 
relevant residues (Lys73 and Asn170) due to their capability to form H-bonds with the 
polar atoms that in this ligand are present in great quantity. 
In the complex TEM-201/Methicillin the same HS has been identified (Tyr105 with 
ΔΔGbinding=2.38 ± 0.65 kcalmol
-1) but in this complex it only interacts with the bicyclic 
structure of the antibiotic and its methyl substituents. 
The residues Asn170 and Glu239 have shown to be important to the stability of the 
complex, the first because it helps stabilizing the core of the antibiotic (hydrophobic 
contacts) and the latter for its complementary with the ortho-dimethoxyphenyl group, 
which also helps avoiding hindrance of the side chain. 
 Near Glu166 water molecules have been identified in both complexes but in none of the 
cases was identified one that stayed for more than 25% of the MD simulation time. Highly 
conserved water molecules were identified near Ser70 for both complexes and other near 
Lys73 for TEM-180/Methicillin. 
It is important to refer that although there is not a conserved water molecule near Glu166 
or in the case of the complex with TEM-201, near Lys73. 
Other data that supports the strong possibility of these TEM variants being capable of 
acylate Methicillin is the fact that the distance between the Oγ of Ser70 (performs the 
nucleophilic attack after hydrogen abstraction by other base) and the carbon from the 
carbonyl group (C5) of the β-lactam ring is small through the MD simulation – maximum 
distance of 10Å with an average of 8 Å  for TEM-201 and an average of 7Å for TEM-
180.(Figure 30). Although these distances are high it is important to note that along the 
MD simulation much lower values can be found (less than 6 Å).  
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The number of water molecules at 4Å of Ser70 has also increased when compared to 
other complexes (4.76Å in TEM-180 and 3.56Å in TEM-201. In other complexes the 
number of water molecules at 4Å of this residue is usually lower than 1.5). The presence 
of new water molecules near this residue might also give the capability to acylate this 
antibiotic with the nucleophilic attack being performed by a water molecule. 
 
 
Figure 30: Graphical representation of the distance between Ser70-Oγ and Methicillin-C5 along the MD simulation, 
for the complexes TEM-201/Methicillin (A) and TEM-180/Methicillin (B). 
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Figure 31: On the left panels are the complexes structures rendered in pymol112 (blue for TEM-180 and red for TEM-
201) and on the right panels are interaction maps made with ligplot108. The complexes correspond to the average 
structures from the MD 
 
4.3.8. Hot spot analysis 
As proposed with the O-ring structure, HS have shown to be shielded from water 
molecules. Even Tyr105 directly faces the solvent and has an important role in protecting 
the catalytic pocket from it, it still presents low number of water molecules for all the 
complexes when compared with other exposed residues. In all complexes this residue 
have shown similar behavior for RDFs even when it is not detected as HS. Therefor only 
one graphic of the calculated RDFs is shown as an example (Figure 32). 
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Figure 32: Graphical representation of the calculated RDFs of Tyr105, for the TEM-180/Ampicillin complex. 
 
Glu239 that has been identified as HS in TEM-201/Amoxicillin complex (ΔΔGbinding=7.86 ± 
0.72 kcalmol-1) and in other complexes has been identified as being important for the 
binding (Table 11). Glu239 is located in the extremity of β3 and has a relevant role for the 
stabilization of the ligand (discussed in sections 4.3.1 to 4.3.7). Due to its location is 
expected to have contact with water molecules and even protect the ligand from it.  
 
 
Figure 33: Graphical representation of the calculated RDFs of Glu239, for the TEM-201/Amoxicillin complex. 
 
It is noticeable that residues that present a higher number of water molecules for all 
complexes have never been identified as HS, with the exception of the previously 
discussed Glu239 in TEM-201/Amoxicillin complex. This is, again in agreement with the 
proposed O-ring theory. 
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Because of the limitations of the ASM methodology (previously discussed in section 1.4.7) 
contributions of the backbone atoms cannot be estimated and Ala and Gly residues could 
not be analyzed with this protocol. As shown in the analysis of the complexes (sections 
4.3.1-4.3.7) Ala237 has an important role for the stabilization of the ligand molecule for 
several complexes due to its capability to form H-bonds between its amino and carbonyl 
groups and the polar atoms of the ligand (both in the bicyclic structure and side chain). 
Therefore, this residue is likely to have a great contribution for the free binding energy of 
the various complexes  
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5. Experimental results 
The halos were measured and registered, after 24h at 37°C. 
We chose to follow the procedure described previously (Experimental Methods) to 
ensure that the bacteria, which we use to perform the susceptibility tests, only produce 
the enzymes required for this study. 
As shown in Table 12 the cloned bacteria are resistant to combinations of combinations 
of β-lactam antibiotics/β-lactamase inhibitors as bacteria presented a normal grow, 
without the formation of a halo. These combinations are TZP and APSM. Normal bacteria 
growth was also observed when using disks with penicillin G, FD, SXT, VA, SAM, CEC, LZD 
and DA. These results show that the cloned E. coli is resistant to these antibiotics due to 
the catalytic action of the TEM variants. 
Several halos were measured with radii under 10mm. This might be due to the fact that 
the enzymes have the ability to acylate the antibiotics. Nevertheless, this acylation is not 
as efficient as in the cases where no halo was formed. 
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Table 12: Radii, in mm, of the halo observed in the antibiotic susceptibility test 
 
 
 
 
 
TEM-201
TEM-180 15
13
CXM TZP AZM
11
12
15
15
NA 9
10
NA
NA
6
6NA
11
12
CAZ APSM CTX FOX CRO
TEM-201
TEM-180
SAM
NA
NA
14
15
NA
NA NA
NA
11
10
13
10 14
14 11
10
OX P CIP NOR LEV MXF F
TEM-201
TEM-180 NA
NA
11
12 NA
15
15
14
14
E TOB DA
NA
NA
10
9
7
5
NA
CN FD SXT IMI VA
TEM-201
TEM-180 7 NA49NANA
5 NANA6NANA
CLR CEC TEC MUP RD LZD
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6. Comparison of results obtained from the methodologies followed 
The complexes analyzed with the computational methodologies part were ampicillin, 
amoxicillin, methicillin, clavulanic acid, cefpirome, Imipenem and Meropenem. In the 
susceptibility experiments we used CAZ, SAM, CTX, FOX, CRO, CXM, TZP, CN, FD, SXT,IMI, 
VA, E, TOB, OX, P ,CIP, NOR, LEV, MXF, F, CLR, CFC, TEC, MUP, RD and L. Although many 
several antibiotics analyzed with computational methodologies were not tested, some 
are closely related (methicillin and oxacillin are very similar penicillins but oxacillin has 
been replacing methicillin in clinical use). The inhibitors always inhibit β-lactamases as 
discussed in 1.2.4 Inhibitors resistant beta lactamases - IRT and therefore, resistance to 
these antibiotics can be compared in this study. 
The predicted activity of TEM-180 and TEM-201 with computational methods is 
supported by the experimental results obtained (Table 12). The ability to resist to 
inhibition is supported by the structural data that shows an increased distance between 
Ser70 and Ser130 avoiding the formation of the intermediate. Therefore, it leads to the 
irreversible inactivation of Ser130 and ultimately the enzyme. 
Experimentally, our computational hypotheses were verified. These enzymes have the 
capability to acylate several penicillins, even those, classified as penicillinase-resistant 
penicillins (used to treat infections caused by Gram-positive bacteria such as S. aureus).  
The cloned E. coli was not resistant to Imipenem and as discussed in 4.3.5 Analysis of 
complexes with Imipenem. It can result from the exposure of the antibiotic to the solvent 
molecules in TEM-180/Imipenem complex. In TEM-201/Imipenem complex, no conserved 
water molecule was identified near Glu166.  
These results show that methodologies used in Computational Biochemistry are very 
reliable and can be used to justify the activity of enzymes. Although it would be possible 
to obtain the results experimentally, it will be time and money expensive. 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
Chapter IV – Conclusion & Future Prospects   
  
 
 
 
 
 
 
 
 
 
 
 
 
  
Chapter IV – Conclusion & Future Prospects 
Conclusion 
 
135 
7. Conclusion 
The objectives proposed for this study were fulfilled. The structures of the two enzymes 
studied were obtained and major studied differences between them and TEM-1 were 
appointed. The two mutants present differences in several secondary structures. The 
most noticeable and also related to the phenotype presented by them are the differences 
observed between β3 and β4-H11 and also the displacement of the α-helices on the 
opposite side of the catalytic pocket, relatively to H11. These modifications are similar in 
TEM-180 and TEM-201, although they are more marked in TEM-201. These facts can be 
appointed as the reasons why these enzymes can acylate antibiotics with bulky side chain 
and even protect the side chain of antibiotics like methicillin from solvent allowing its 
degradation. The displacement of the helical structures close to Ser130 and Ser70 are 
likely the cause to their capability to resist to inhibition due to increased distance 
between these residues. 
In the literature, it has been described that this type of enzymes acquires either the 
capability to resist to inhibition or the capability to hydrolyzed very large antibiotics. It 
was demonstrated in this study that both variants under study present characteristics 
that allow them to be simultaneously resistant to inhibition and capable of hydrolyzing 
large antibiotics. This might be the effect of high plasticity of the enzymes to the 
antibiotics, allowing them to form a strong complex with a variety of antibiotics. These 
complexes show significant differences in structural (orientation of side chains, presence 
of water molecules and modifications in secondary structures) and energetic (HS can vary 
depending on the antibiotic) terms. 
Computational ASM have shown that some residues are responsible for an important 
contribution for the binding free energy in a great number of the analyzed complexes. 
Tyr105 was identified as HS in almost all the complexes and presented a low number of 
water molecules, even though is facing the exterior of the catalytic pocket. Although, 
Glu166 and Lys73 are typically described as very important for the acylation of antibiotics 
due to their role in the hydrogen transfer network, they have been identified as HS in 
several complexes. This shows that their role for enzymatic catalysis is not only for proton 
transfer but they can also play a key role in stabilization of the ligand. Ala237 could not be 
analyzed with computational ASM but it was an interacting residue in most complexes, 
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with the ligands. These interactions seem to help stabilizing the ligand (bicyclic structure 
and side chain). 
The distance between Ser70 and Ser130 has been appointed as the reason why these 
enzymes resist inhibition. As described in 1.2.4 Inhibitors resistant beta lactamases - IRT, 
this fact usually leads to decreased acylation of other antibiotics. However, in both TEMs 
studied that does not appear to be the case since the cloned E. coli have presented 
resistance to several antibiotics. This has to be confirmed in further experiments. 
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8. Future Prospects 
Given the apparent complexity of TEM-180 and TEM201, several properties need to be 
investigated with computational and experimental methodologies. 
The next step in Computational biochemistry will be to characterize the secondary 
structures observed in TEM-1. This will be investigated plotting DSSP Helix/Sheet 
assignments and estimating the structural variance of several secondary structures. 
Within the experimental methodologies, enzymatic kinetics will be calculated with several 
antibiotics, as well as, the ability of these plasmids to allow other bacteria (i.e. S. aureus) 
to resist to antibiotics such as methicillin and oxacillin. It is still necessary to perform 
susceptibility tests with all the antibiotics that were tested with computational 
methodologies. 
Obtaining the X-ray structures of both TEM-180 and TEM-201 would also be very 
important. 
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9. Supporting Information (S.I.) 
 
 
Figure 34: Graphic representation of the RMSD of the TEM-180/Amoxicillin complex. In blue is the RMSD for the 
protein backbone and in green the RMSD of Amoxicillin 
 
Figure 35: Graphic representation of the RMSD of the TEM-201/Amoxicillin complex. In blue is the RMSD for the 
protein backbone and in green the RMSD of Amoxicillin 
 
Figure 36: Graphic representation of the RMSD of the TEM-1/Amoxicillin complex. In blue is the RMSD for the protein 
backbone and in green the RMSD of Amoxicillin 
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Figure 37: Graphic representation of the RMSD of the TEM-180/Clavulanic acid. In blue is the RMSD for the protein 
backbone and in green the RMSD of Clavulanic acid 
 
 
Figure 38: Graphic representation of the RMSD of the TEM-201/Clavulanic acid. In blue is the RMSD for the protein 
backbone and in green the RMSD of Clavulanic acid 
 
 
Figure 39: Graphic representation of the RMSD of the TEM-1/Clavulanic acid. In blue is the RMSD for the protein 
backbone and in green the RMSD of Clavulanic acid 
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Figure 40: Graphic representation of the RMSD of the TEM-180/Cefpirome. In blue is the RMSD for the protein 
backbone and in green the RMSD of Cefpirome 
 
 
Figure 41: Graphic representation of the RMSD of the TEM-201/Cefpirome. In blue is the RMSD for the protein 
backbone and in green the RMSD of Cefpirome 
 
 
Figure 42: Graphic representation of the RMSD of the TEM-180/Imipenem. In blue is the RMSD for the protein 
backbone and in green the RMSD of Imipenem 
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Figure 43: Graphic representation of the RMSD of the TEM-201/Imipenem. In blue is the RMSD for the protein 
backbone and in green the RMSD of Imipenem 
 
 
Figure 44: Graphic representation of the RMSD of the TEM-180/Meropenem. In blue is the RMSD for the protein 
backbone and in green the RMSD of Meropenem 
 
 
Figure 45: Graphic representation of the RMSD of the TEM-201/Meropenem. In blue is the RMSD for the protein 
backbone and in green the RMSD of Meropenem 
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Figure 46: Graphic representation of the RMSD of the TEM-180/Methicillin. In blue is the RMSD for the protein 
backbone and in green the RMSD of Methicillin 
 
 
Figure 47: Graphic representation of the RMSD of the TEM-201/Methicillin. In blue is the RMSD for the protein 
backbone and in green the RMSD of Methicillin 
  
  
146 
 
  
147 
 
 
 
 
 
 
 
 
 
Chapter VI – Bibliography   
  
148 
 
Chapter VI – Bibliography 
 
149 
10. Bibliography 
1.Bradford, P. A., Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and 
detection of this important resistance threat. Clin Microbiol Rev 2001, 14, 933-51, table of contents. 
2.Salverda, M. L.; De Visser, J. A.; Barlow, M., Natural evolution of TEM-1 β-lactamase: experimental reconstruction 
and clinical relevance. FEMS Microbiol Rev 2010, 34, 1015-36. 
3.Bush, K., The evolution of beta-lactamases. Ciba Found Symp 1997, 207, 152-63; discussion 163-6. 
4.Bush, K., beta-Lactamases of increasing clinical importance. Curr Pharm Des 1999, 5, 839-45. 
5.Fisher, J. F.; Meroueh, S. O.; Mobashery, S., Bacterial Resistance to β-Lactam Antibiotics:  Compelling Opportunism, 
Compelling Opportunity†. Chemical Reviews 2005, 105, 395-424. 
6.Llarrull, L. I.; Testero, S. A.; Fisher, J. F.; Mobashery, S., The future of the β-lactams. Current Opinion in Microbiology 
2010, 13, 551-557. 
7.Wilke, M. S.; Lovering, A. L.; Strynadka, N. C. J., β-Lactam antibiotic resistance: a current structural perspective. 
Current Opinion in Microbiology 2005, 8, 525-533. 
8.Abraham Ep Fau - Chain, E.; Chain, E., An enzyme from bacteria able to destroy penicillin. 1940. 
9.Bush, K.; Fisher, J. F., Epidemiological Expansion, Structural Studies, and Clinical Challenges of New beta-
Lactamases from Gram-Negative Bacteria. In Annual Review of Microbiology, Vol 65, Gottesman, S.; Harwood, C. S., 
Eds. Annual Reviews: Palo Alto, 2011; Vol. 65, pp 455-478. 
10.Bös, F.; Pleiss, J., Conserved Water Molecules Stabilize the Ω-Loop in Class A β-Lactamases. Antimicrobial Agents 
and Chemotherapy 2008, 52, 1072-1079. 
11.Stapleton, P. D.; Shannon, K. P.; French, G. L., Construction and characterization of mutants of the TEM-1 beta-
lactamase containing amino acid substitutions associated with both extended-spectrum resistance and resistance to 
beta-lactamase inhibitors. Antimicrob Agents Chemother 1999, 43, 1881-7. 
12.Wang, X.; Minasov, G.; Shoichet, B. K., Evolution of an antibiotic resistance enzyme constrained by stability and 
activity trade-offs. J Mol Biol 2002, 320, 85-95. 
13.Stec, B.; Holtz, K. M.; Wojciechowski, C. L.; Kantrowitz, E. R., Structure of the wild-type TEM-1 beta-lactamase at 
1.55 A and the mutant enzyme Ser70Ala at 2.1 A suggest the mode of noncovalent catalysis for the mutant enzyme. 
Acta Crystallogr D Biol Crystallogr 2005, 61, 1072-9. 
14.Bush, K.; Jacoby, G., Nomenclature of TEM beta-lactamases. J Antimicrob Chemother 1997, 39, 1-3. 
15.Doucet, N.; Savard, P. Y.; Pelletier, J. N.; Gagné, S. M., NMR investigation of Tyr105 mutants in TEM-1 beta-
lactamase: dynamics are correlated with function. J Biol Chem 2007, 282, 21448-59. 
16.Bernstein, F. C.; Koetzle, T. F.; Williams, G. J.; Meyer, E. F.; Brice, M. D.; Rodgers, J. R.; Kennard, O.; Shimanouchi, 
T.; Tasumi, M., The Protein Data Bank. A computer-based archival file for macromolecular structures. Eur J Biochem 
1977, 80, 319-24. 
17.Fisette, O.; Morin, S.; Savard, P. Y.; Lagüe, P.; Gagné, S. M., TEM-1 backbone dynamics-insights from combined 
molecular dynamics and nuclear magnetic resonance. Biophys J 2010, 98, 637-45. 
18.Minasov, G.; Wang, X.; Shoichet, B. K., An ultrahigh resolution structure of TEM-1 beta-lactamase suggests a role 
for Glu166 as the general base in acylation. J Am Chem Soc 2002, 124, 5333-40. 
19.Page, M. G., Extended-spectrum beta-lactamases: structure and kinetic mechanism. Clin Microbiol Infect 2008, 14 
Suppl 1, 63-74. 
20.Meroueh, S. O.; Roblin, P.; Golemi, D.; Maveyraud, L.; Vakulenko, S. B.; Zhang, Y.; Samama, J. P.; Mobashery, S., 
Molecular dynamics at the root of expansion of function in the M69L inhibitor-resistant TEM beta-lactamase from 
Escherichia coli. J Am Chem Soc 2002, 124, 9422-30. 
21.Thomas, V. L.; Golemi-Kotra, D.; Kim, C.; Vakulenko, S. B.; Mobashery, S.; Shoichet, B. K., Structural consequences 
of the inhibitor-resistant Ser130Gly substitution in TEM beta-lactamase. Biochemistry 2005, 44, 9330-8. 
22.Massova, I.; Kollman, P. A., pKa, MM, and QM studies of mechanisms of β-lactamases and penicillin-binding 
proteins: Acylation step. Journal of Computational Chemistry 2002, 23, 1559-1576. 
23.Hermann, J. C.; Pradon, J.; Harvey, J. N.; Mulholland, A. J., High level QM/MM modeling of the formation of the 
tetrahedral intermediate in the acylation of wild type and K73A mutant TEM-1 class A beta-lactamase. J Phys Chem A 
2009, 113, 11984-94. 
24.Brown, N. G.; Pennington, J. M.; Huang, W.; Ayvaz, T.; Palzkill, T., Multiple global suppressors of protein stability 
defects facilitate the evolution of extended-spectrum TEM β-lactamases. J Mol Biol 2010, 404, 832-46. 
25.Jacoby, G. ß-Lactamase Classification and Amino Acid Sequences for TEM, SHV and OXA Extended-Spectrum and 
Inhibitor Resistant Enzymes. http://www.lahey.org/Studies/. 
26.Wang, X.; Minasov, G.; Shoichet, B. K., The structural bases of antibiotic resistance in the clinically derived mutant 
beta-lactamases TEM-30, TEM-32, and TEM-34. J Biol Chem 2002, 277, 32149-56. 
27.Brown, N. G.; Shanker, S.; Prasad, B. V.; Palzkill, T., Structural and biochemical evidence that a TEM-1 beta-
lactamase N170G active site mutant acts via substrate-assisted catalysis. J Biol Chem 2009, 284, 33703-12. 
28.Marciano, D. C.; Pennington, J. M.; Wang, X.; Wang, J.; Chen, Y.; Thomas, V. L.; Shoichet, B. K.; Palzkill, T., Genetic 
and structural characterization of an L201P global suppressor substitution in TEM-1 beta-lactamase. J Mol Biol 2008, 
384, 151-64. 
29.Knox, J. R., Extended-spectrum and inhibitor-resistant TEM-type beta-lactamases: mutations, specificity, and 
three-dimensional structure. Antimicrob Agents Chemother 1995, 39, 2593-601. 
  
150 
30.Saves, I.; Burlet-Schiltz, O.; Swarén, P.; Lefèvre, F.; Masson, J. M.; Promé, J. C.; Samama, J. P., The asparagine to 
aspartic acid substitution at position 276 of TEM-35 and TEM-36 is involved in the beta-lactamase resistance to 
clavulanic acid. J Biol Chem 1995, 270, 18240-5. 
31.Chaïbi, E. B.; Sirot, D.; Paul, G.; Labia, R., Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and 
biochemical characteristics. J Antimicrob Chemother 1999, 43, 447-58. 
32.Swarén, P.; Golemi, D.; Cabantous, S.; Bulychev, A.; Maveyraud, L.; Mobashery, S.; Samama, J. P., X-ray structure 
of the Asn276Asp variant of the Escherichia coli TEM-1 beta-lactamase: direct observation of electrostatic 
modulation in resistance to inactivation by clavulanic acid. Biochemistry 1999, 38, 9570-6. 
33.Vakulenko, S.; Golemi, D., Mutant TEM beta-lactamase producing resistance to ceftazidime, ampicillins, and beta-
lactamase inhibitors. Antimicrob Agents Chemother 2002, 46, 646-53. 
34.Robin, F.; Delmas, J.; Schweitzer, C.; Tournilhac, O.; Lesens, O.; Chanal, C.; Bonnet, R., Evolution of TEM-type 
enzymes: biochemical and genetic characterization of two new complex mutant TEM enzymes, TEM-151 and TEM-
152, from a single patient. Antimicrob Agents Chemother 2007, 51, 1304-9. 
35.Chaibi, E. B.; Péduzzi, J.; Farzaneh, S.; Barthélémy, M.; Sirot, D.; Labia, R., Clinical inhibitor-resistant mutants of the 
beta-lactamase TEM-1 at amino-acid position 69. Kinetic analysis and molecular modelling. Biochim Biophys Acta 
1998, 1382, 38-46. 
36.Jelsch, C.; Mourey, L.; Masson, J. M.; Samama, J. P., Crystal structure of Escherichia coli TEM1 beta-lactamase at 
1.8 A resolution. Proteins 1993, 16, 364-83. 
37.Giakkoupi, P.; Hujer, A. M.; Miriagou, V.; Tzelepi, E.; Bonomo, R. A.; Tzouvelekis, L. S., Substitution of Thr for Ala-
237 in TEM-17, TEM-12 and TEM-26: alterations in beta-lactam resistance conferred on Escherichia coli. FEMS 
Microbiol Lett 2001, 201, 37-40. 
38.Cantu, C.; Palzkill, T., The role of residue 238 of TEM-1 beta-lactamase in the hydrolysis of extended-spectrum 
antibiotics. J Biol Chem 1998, 273, 26603-9. 
39.Blázquez, J.; Negri, M. C.; Morosini, M. I.; Gómez-Gómez, J. M.; Baquero, F., A237T as a modulating mutation in 
naturally occurring extended-spectrum TEM-type beta-lactamases. Antimicrob Agents Chemother 1998, 42, 1042-4. 
40.Labia, R.; Morand, A.; Tiwari, K.; Sirot, J.; Sirot, D.; Petit, A., Interactions of new plasmid-mediated beta-
lactamases with third-generation cephalosporins. Rev Infect Dis 1988, 10, 885-91. 
41.Venkatachalam, K. V.; Huang, W.; LaRocco, M.; Palzkill, T., Characterization of TEM-1 beta-lactamase mutants 
from positions 238 to 241 with increased catalytic efficiency for ceftazidime. J Biol Chem 1994, 269, 23444-50. 
42.Imtiaz, U.; Manavathu, E. K.; Mobashery, S.; Lerner, S. A., Reversal of clavulanate resistance conferred by a Ser-
244 mutant of TEM-1 beta-lactamase as a result of a second mutation (Arg to Ser at position 164) that enhances 
activity against ceftazidime. Antimicrob Agents Chemother 1994, 38, 1134-9. 
43.Kong, K.-F.; Schneper, L.; Mathee, K., Beta-lactam antibiotics: from antibiosis to resistance and bacteriology. 
APMIS 2010, 118, 1-36. 
44.Chen, Y.; Zhang, W.; Shi, Q.; Hesek, D.; Lee, M.; Mobashery, S.; Shoichet, B. K., Crystal Structures of Penicillin-
Binding Protein 6 from Escherichia coli. Journal of the American Chemical Society 2009, 131, 14345-14354. 
45.Knox, J. R.; Moews, P. C.; Frere, J.-M., Molecular evolution of bacterial ²-lactam resistance. Chemistry & biology 
1996, 3, 937-947. 
46.Long, A. J.; Clifton, I. J.; Roach, P. L.; Baldwin, J. E.; Rutledge, P. J.; Schofield, C. J., Structural studies on the reaction 
of isopenicillin N synthase with the truncated substrate analogues delta-(L-alpha-aminoadipoyl)-L-cysteinyl-glycine 
and delta-(L-alpha-aminoadipoyl)-L-cysteinyl-D-alanine. Biochemistry 2005, 44, 6619-28. 
47.Fonseca, F.; Chudyk, E. I.; van der Kamp, M. W.; Correia, A.; Mulholland, A. J.; Spencer, J., The Basis for 
Carbapenem Hydrolysis by Class A β-Lactamases: A Combined Investigation using Crystallography and Simulations. 
Journal of the American Chemical Society 2012, 134, 18275-18285. 
48.Mainardi, J.-L.; Hugonnet, J.-E.; Rusconi, F.; Fourgeaud, M.; Dubost, L.; Moumi, A. N.; Delfosse, V.; Mayer, C.; 
Gutmann, L.; Rice, L. B.; Arthur, M., Unexpected Inhibition of Peptidoglycan LD-Transpeptidase from Enterococcus 
faecium by the β-Lactam Imipenem. Journal of Biological Chemistry 2007, 282, 30414-30422. 
49.Sacco, E.; Hugonnet, J.-E.; Josseaume, N.; Cremniter, J.; Dubost, L.; Marie, A.; Patin, D.; Blanot, D.; Rice, L. B.; 
Mainardi, J.-L.; Arthur, M., Activation of the l,d-transpeptidation peptidoglycan cross-linking pathway by a metallo-
d,d-carboxypeptidase in Enterococcus faecium. Molecular Microbiology 2010, 75, 874-885. 
50.Hellinger, W. C.; Brewer, N. S., Carbapenems and monobactams: imipenem, meropenem, and aztreonam. Mayo 
Clin Proc 1999, 74, 420-34. 
51.Brewer, N. S.; Hellinger, W. C., The monobactams. Mayo Clin Proc 1991, 66, 1152-7. 
52.Drawz, S. M.; Bonomo, R. A., Three decades of beta-lactamase inhibitors. Clin Microbiol Rev 2010, 23, 160-201. 
53.Akova, M., Sulbactam-containing beta-lactamase inhibitor combinations. Clin Microbiol Infect 2008, 14 Suppl 1, 
185-8. 
54.Livermore, D. M.; Hope, R.; Mushtaq, S.; Warner, M., Orthodox and unorthodox clavulanate combinations against 
extended-spectrum beta-lactamase producers. Clin Microbiol Infect 2008, 14 Suppl 1, 189-93. 
55.Oelschlaeger, P.; Ai, N.; Duprez, K. T.; Welsh, W. J.; Toney, J. H., Evolving carbapenemases: can medicinal chemists 
advance one step ahead of the coming storm? J Med Chem 2010, 53, 3013-27. 
56.Allinger, N. L., Understanding molecular structure from molecular mechanics. J Comput Aided Mol Des 2011, 25, 
295-316. 
57.Leach, A. R., Molecular Modelling - Principles and applications. second edition ed.; 2001. 
Chapter VI – Bibliography 
 
151 
58.Ramachandran, K. I.; Deepa, G.; Namboori, K., Computational Chemistry and Molecular Modeling - Principles and 
Applications. Springer-Verlag Berlin Heidelberg: 2008. 
59.Case, D. A.; Cheatham, T. E.; Darden, T.; Gohlke, H.; Luo, R.; Merz, K. M.; Onufriev, A.; Simmerling, C.; Wang, B.; 
Woods, R. J., The Amber biomolecular simulation programs. J Comput Chem 2005, 26, 1668-88. 
60.Brooks, B. R.; Brooks, C. L.; Mackerell, A. D.; Nilsson, L.; Petrella, R. J.; Roux, B.; Won, Y.; Archontis, G.; Bartels, C.; 
Boresch, S.; Caflisch, A.; Caves, L.; Cui, Q.; Dinner, A. R.; Feig, M.; Fischer, S.; Gao, J.; Hodoscek, M.; Im, W.; Kuczera, 
K.; Lazaridis, T.; Ma, J.; Ovchinnikov, V.; Paci, E.; Pastor, R. W.; Post, C. B.; Pu, J. Z.; Schaefer, M.; Tidor, B.; Venable, R. 
M.; Woodcock, H. L.; Wu, X.; Yang, W.; York, D. M.; Karplus, M., CHARMM: the biomolecular simulation program. J 
Comput Chem 2009, 30, 1545-614. 
61.Hetzel, R.; Wüthrich, K.; Deisenhofer, J.; Huber, R., Dynamics of the aromatic amino acid residues in the globular 
conformation of the basic pancreatic trypsin inhibitor (BPTI). II. Semi-empirical energy calculations. Biophys Struct 
Mech 1976, 2, 159-80. 
62.Alder, B. J.; Wainwright, T. E., Studies in Molecular Dynamics. I. General Method. Journal of Chemical Physics 
1959, 31. 
63. Rahman, A., Correlations in the Motion of Atoms in Liquid Argon. Physical Review 1964, 136, A405-A411. 
64.Karplus, M.; McCammon, J. A., Molecular dynamics simulations of biomolecules. Nat Struct Mol Biol 2002, 9, 646-
652. 
65.Chandler, D., Introduction to Modern Statistical Mechanics. Oxford University Press, 1987; p 288. 
66.Ryckaert, J.-P.; Ciccotti, G.; Berendsen, H. J. C., Numerical integration of the cartesian equations of motion of a 
system with constraints: molecular dynamics of n-alkanes. Journal of Computational Physics 1977, 23, 327-341. 
67.William, G. H., Computational Statistical Mechanics. Elsevier Science Publishers Ltd.: 1991; p 314. 
68.Nose, S., A unified formulation of the constant temperature molecular dynamics methods. The Journal of 
Chemical Physics 1984, 81, 511-519. 
69.Berendsen, H. J. C.; Postma, J. P. M.; van Gunsteren, W. F.; DiNola, A.; Haak, J. R., Molecular dynamics with 
coupling to an external bath. The Journal of Chemical Physics 1984, 81, 3684-3690. 
70.Loncharich, R. J.; Brooks, B. R.; Pastor, R. W., Langevin dynamics of peptides: The frictional dependence of 
isomerization rates of N-acetylalanyl-N′-methylamide. Biopolymers 1992, 32, 523-535. 
71.Izaguirre, J. A.; Catarello, D. P.; Wozniak, J. M.; Skeel, R. D., Langevin stabilization of molecular dynamics. The 
Journal of Chemical Physics 2001, 114, 2090-2098. 
72.Darden, T.; York, D.; Pedersen, L., Particle mesh Ewald: An N [center-dot] log(N) method for Ewald sums in large 
systems. The Journal of Chemical Physics 1993, 98, 10089-10092. 
73.Ewald, P. P., Die Berechnung optischer und elektrostatischer Gitterpotentiale. Annalen der Physik 1921, 369, 253-
287. 
74.Essmann, U.; Perera, L.; Berkowitz, M. L.; Darden, T.; Lee, H.; Pedersen, L. G., A smooth particle mesh Ewald 
method. The Journal of Chemical Physics 1995, 103, 8577-8593. 
75.Sagui, C.; Darden, T. A., Molecular dynamics simulations of biomolecules: long-range electrostatic effects. Annu 
Rev Biophys Biomol Struct 1999, 28, 155-79. 
76. Teague, S. J., Implications of protein flexibility for drug discovery. Nat Rev Drug Discov 2003, 2, 527-41. 
77.Carlson, H. A., Protein flexibility and drug design: how to hit a moving target. Curr Opin Chem Biol 2002, 6, 447-52. 
78.Carlson, H. A., Protein flexibility is an important component of structure-based drug discovery. Curr Pharm Des 
2002, 8, 1571-8. 
79.Sousa, S. F.; Fernandes, P. A.; Ramos, M. J., Protein-ligand docking: current status and future challenges. Proteins 
2006, 65, 15-26. 
80.Schnecke, V.; Swanson, C. A.; Getzoff, E. D.; Tainer, J. A.; Kuhn, L. A., Screening a peptidyl database for potential 
ligands to proteins with side-chain flexibility. Proteins 1998, 33, 74-87. 
81.Hart, T. N.; Read, R. J., A multiple-start Monte Carlo docking method. Proteins 1992, 13, 206-22. 
82.Oshiro, C. M.; Kuntz, I. D.; Dixon, J. S., Flexible ligand docking using a genetic algorithm. J Comput Aided Mol Des 
1995, 9, 113-30. 
83.Kitchen, D. B.; Decornez, H.; Furr, J. R.; Bajorath, J., Docking and scoring in virtual screening for drug discovery: 
methods and applications. Nat Rev Drug Discov 2004, 3, 935-49. 
84.Bissantz, C.; Folkers, G.; Rognan, D., Protein-based virtual screening of chemical databases. 1. Evaluation of 
different docking/scoring combinations. J Med Chem 2000, 43, 4759-67. 
85.Kawatkar, S.; Moustakas, D.; Miller, M.; Joseph-McCarthy, D., Virtual fragment screening: exploration of MM-
PBSA re-scoring. J Comput Aided Mol Des 2012, 26, 921-34. 
86.Morris, G. M.; Huey, R.; Lindstrom, W.; Sanner, M. F.; Belew, R. K.; Goodsell, D. S.; Olson, A. J., AutoDock4 and 
AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 2009, 30, 2785-91. 
87.Huey, R.; Morris, G. M.; Olson, A. J.; Goodsell, D. S., A semiempirical free energy force field with charge-based 
desolvation. J Comput Chem 2007, 28, 1145-52. 
88.Kollman, P., Free energy calculations: Applications to chemical and biochemical phenomena. Chemical Reviews 
1993, 93, 2395-2417. 
89.Hou, T.; Wang, J.; Li, Y.; Wang, W., Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The 
accuracy of binding free energy calculations based on molecular dynamics simulations. J Chem Inf Model 2011, 51, 
69-82. 
  
152 
90.Fogolari, F.; Brigo, A.; Molinari, H., Protocol for MM/PBSA Molecular Dynamics Simulations of Proteins. 
Biophysical Journal 2003, 85, 159-166. 
91.Massova, I.; Kollman, P., Combined molecular mechanical and continuum solvent approach (MM-PBSA/GBSA) to 
predict ligand binding. Perspectives in Drug Discovery and Design 2000, 18, 113-135. 
92.Moreira, I. S.; Fernandes, P. A.; Ramos, M. J., Computational alanine scanning mutagenesis--an improved 
methodological approach. J Comput Chem 2007, 28, 644-54. 
93.Clackson, T.; Wells, J. A., A hot spot of binding energy in a hormone-receptor interface. Science (New York, N.Y.) 
1995, 267, 383-386. 
94.Moreira, I. S.; Fernandes, P. A.; Ramos, M. J., Hot spots--a review of the protein-protein interface determinant 
amino-acid residues. Proteins 2007, 68, 803-12. 
95.Bogan, A. A.; Thorn, K. S., Anatomy of hot spots in protein interfaces. J Mol Biol 1998, 280, 1-9. 
96.Moreira, I. S.; Fernandes, P. A.; Ramos, M. J., Hot spot occlusion from bulk water: a comprehensive study of the 
complex between the lysozyme HEL and the antibody FVD1.3. J Phys Chem B 2007, 111, 2697-706. 
97.Clackson, T.; Wells, J. A., A hot spot of binding energy in a hormone-receptor interface. Science 1995, 267, 383-6. 
98.Thorn Ks Fau - Bogan, A. A.; Bogan, A. A., ASEdb: a database of alanine mutations and their effects on the free 
energy of binding in protein interactions. 
99.Conte, L. L.; Chothia, C.; Janin, J., The atomic structure of protein-protein recognition sites. Journal of Molecular 
Biology 1999, 285, 2177-2198. 
100.Lichtarge O Fau - Bourne, H. R.; Bourne Hr Fau - Cohen, F. E.; Cohen, F. E., An evolutionary trace method defines 
binding surfaces common to protein families. 
101.Moreira, I. S.; Martins, J. M.; Ramos, R. M.; Fernandes, P. A.; Ramos, M. J., Understanding the importance of the 
aromatic amino-acid residues as hot-spots. Biochim Biophys Acta 2012. 
102.Thompson, J. D.; Higgins, D. G.; Gibson, T. J., CLUSTAL W: improving the sensitivity of progressive multiple 
sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic 
Acids Research 1994, 22, 4673-4680. 
103.Schrödinger, L. Maestro, version 9.2, 2011. 
104.Cornell, W. D.; Cieplak, P.; Bayly, C. I.; Gould, I. R.; Merz, K. M.; Ferguson, D. M.; Spellmeyer, D. C.; Fox, T.; 
Caldwell, J. W.; Kollman, P. A., A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and 
Organic Molecules. Journal of the American Chemical Society 1995, 117, 5179-5197. 
105.Duan, Y.; Wu, C.; Chowdhury, S.; Lee, M. C.; Xiong, G.; Zhang, W.; Yang, R.; Cieplak, P.; Luo, R.; Lee, T.; Caldwell, 
J.; Wang, J.; Kollman, P., A point-charge force field for molecular mechanics simulations of proteins based on 
condensed-phase quantum mechanical calculations. Journal of Computational Chemistry 2003, 24, 1999-2012. 
106.Jorgensen, W. L.; Chandrasekhar, J.; Madura, J. D.; Impey, R. W.; Klein, M. L., Comparison of simple potential 
functions for simulating liquid water. The Journal of Chemical Physics 1983, 79, 926-935. 
107.Bolton, E. E.; Wang, Y.; Thiessen, P. A.; Bryant, S. H., Chapter 12 PubChem: Integrated Platform of Small 
Molecules and Biological Activities. In Annual Reports in Computational Chemistry, Ralph, A. W. a. D. C. S., Ed. 
Elsevier: 2008; Vol. Volume 4, pp 217-241. 
108.Wallace Ac Fau - Laskowski, R. A.; Laskowski Ra Fau - Thornton, J. M.; Thornton, J. M., LIGPLOT: a program to 
generate schematic diagrams of protein-ligand interactions. 
109.Bayly, C. I.; Cieplak, P.; Cornell, W.; Kollman, P. A., A well-behaved electrostatic potential based method using 
charge restraints for deriving atomic charges: the RESP model. The Journal of Physical Chemistry 1993, 97, 10269-
10280. 
110.Wang, J.; Wolf, R. M.; Caldwell, J. W.; Kollman, P. A.; Case, D. A., Development and testing of a general amber 
force field. Journal of Computational Chemistry 2004, 25, 1157-1174. 
111.Humphrey, W.; Dalke, A.; Schulten, K., VMD: Visual molecular dynamics. Journal of Molecular Graphics 1996, 14, 
33-38. 
112. DeLano, W. L., The PyMOL Molecular Graphics System. DeLano Scientific, San Carlos, CA, USA.: 2002. 
113.Huo, S.; Massova, I.; Kollman, P. A., Computational alanine scanning of the 1 : 1 human growth hormone-
receptor complex. Journal of Computational Chemistry 2002, 23, 15-27. 
114.D.A. Case, T. A. D., T.E. Cheatham, III, C.L. Simmerling, J. Wang, R.E. Duke, R. Luo,; M. Crowley, R. C. W., W. 
Zhang, K.M. Merz, B.Wang, S. Hayik, A. Roitberg, G. Seabra, I.; Kolossváry, K. F. W., F. Paesani, J. Vanicek, X.Wu, S.R. 
Brozell, T. Steinbrecher, H. Gohlke,; L. Yang, C. T., J. Mongan, V. Hornak, G. Cui, D.H. Mathews, M.G. Seetin, C. Sagui, 
V. Babin,; Kollman, a. P. A., AMBER 10, University of Calirfonia, San Francisco. 2008. 
115.Moreira, I. S.; Fernandes, P. A.; Ramos, M. J., Detailed microscopic study of the full ZipA : FtsZ interface. Proteins-
Structure Function and Bioinformatics 2006, 63, 811-821. 
116.Moreira, I. S.; Fernandes, P. A.; Ramos, M. J., Unraveling the importance of protein-protein interaction: 
Application of a computational alanine-scanning mutagenesis to the study of the IgG1 streptococcal protein G (C2 
fragment) complex. Journal of Physical Chemistry B 2006, 110, 10962-10969. 
117.Moreira, I. S.; Fernandes, P. A.; Ramos, M. J., Unravelling Hot Spots: a comprehensive computational 
mutagenesis study. Theoretical Chemistry Accounts 2007, 117, 99-113. 
118.Moreira, I. S.; Fernandes, P. A.; Ramos, M. J., Hot spot computational identification: Application to the complex 
formed between the hen egg white lysozyme (HEL) and the antibody HyHEL-10. International Journal of Quantum 
Chemistry 2007, 107, 299-310. 
Chapter VI – Bibliography 
 
153 
119.Moreira, I. S.; Fernandes, P. A.; Ramos, M. J., Computational alanine scanning mutagenesis - An improved 
methodological approach. Journal of Computational Chemistry 2007, 28, 644-654. 
120.Moreira, I. S.; Fernandes, P. A.; Ramos, M. J., Backbone importance for protein-protein binding. Journal of 
Chemical Theory and Computation 2007, 3, 885-893. 
121.Moreira, I. S.; Fernandes, P. A.; Ramos, M. J., Hot spot occlusion from bulk water: A comprehensive study of the 
complex between the lysozyme HEL and the antibody FVD1.3. Journal of Physical Chemistry B 2007, 111, 2697-2706. 
122.Moreira, I. S.; Fernandes, P. A.; Ramos, M. J., Protein-protein recognition: a computational mutagenesis study of 
the MDM2-P53 complex. Theoretical Chemistry Accounts 2008, 120, 533-542. 
123.Chong, L. T.; Duan, Y.; Wang, L.; Massova, I.; Kollman, P. A., Molecular dynamics and free-energy calculations 
applied to affinity maturation in antibody 48G7. Proceedings of the National Academy of Sciences of the United 
States of America 1999, 96, 14330-14335. 
124.Kollman, P. A.; Massova, I.; Reyes, C.; Kuhn, B.; Huo, S. H.; Chong, L.; Lee, M.; Lee, T.; Duan, Y.; Wang, W.; Donini, 
O.; Cieplak, P.; Srinivasan, J.; Case, D. A.; Cheatham, T. E., Calculating structures and free energies of complex 
molecules: Combining molecular mechanics and continuum models. Accounts of Chemical Research 2000, 33, 889-
897. 
125.Bradshaw, R. T.; Patel, B. H.; Tate, E. W.; Leatherbarrow, R. J.; Gould, I. R., Comparing experimental and 
computational alanine scanning techniques for probing a prototypical protein-protein interaction. Protein 
Engineering Design & Selection 2011, 24, 197-207. 
126.Martins, J.; Ramos, R.; Moreira, I., Structural determinats of a typical leucine-rich repeat protein. 
Communications in computational physics 2013, 13, 238-255. 
127.Moreira, I. S.; Martins, J. M.; Ramos, M. J.; Fernandes, P. A.; Ramos, M. J., Understanding the importance of the 
aromatic amino-acid residues as hot-spots. Biochem. Biophys. Acta 2013, 1834, 401-414. 
128.Ribeiro, J. V.; Cerqueira, N. M. F. S. A.; Moreira, I. S.; Fernandes, P. A.; Ramos, M. J., CompASM: an Amber-VMD 
Alanine Scanning Mutagenesis plug-in. Theoretical Chemistry Accounts- In press. 2012. 
129.Rocchia, W.; Alexov, E.; Honig, B., Extending the applicability of the nonlinear Poisson-Boltzmann equation: 
Multiple dielectric constants and multivalent ions. Journal of Physical Chemistry B 2001, 105, 6507-6514. 
130.Rocchia, W.; Sridharan, S.; Nicholls, A.; Alexov, E.; Chiabrera, A.; Honig, B., Rapid grid-based construction of the 
molecular surface and the use of induced surface charge to calculate reaction field energies: Applications to the 
molecular systems and geometric objects. Journal of Computational Chemistry 2002, 23, 128-137. 
131.Moreira, I. S.; Fernandes, P. A.; Ramos, M. J., Accuracy of the numerical solution of the Poisson-Boltzmann 
equation. Journal of Molecular Structure-Theochem 2005, 729, 11-18. 
132.Sitkoff, D.; Sharp, K. A.; Honig, B., Accurate calculation of hydration free-energies using macroscopic solvent 
models Journal of Physical Chemistry 1994, 98, 1978-1988. 
133.Connolly, M. L., Analytical molecular surface calculation Journal of Applied Crystallography 1983, 16, 548-558. 
 
 
